<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK190101" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK190101/" /><meta name="ncbi_pagename" content="Pancreatitis Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Pancreatitis Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Pancreatitis Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/03/13" /><meta name="citation_author" content="Jessica LaRusch" /><meta name="citation_author" content="Sheila Solomon" /><meta name="citation_author" content="David C Whitcomb" /><meta name="citation_pmid" content="24624459" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK190101/" /><meta name="citation_keywords" content="Calcific Pancreatitis" /><meta name="citation_keywords" content="Chronic Pancreatitis" /><meta name="citation_keywords" content="SPINK1-Related Hereditary Pancreatitis" /><meta name="citation_keywords" content="PRSS1-Related Hereditary Pancreatitis" /><meta name="citation_keywords" content="CTRC-Related Hereditary Pancreatitis" /><meta name="citation_keywords" content="CFTR-Related Hereditary Pancreatitis" /><meta name="citation_keywords" content="Bile salt-activated lipase" /><meta name="citation_keywords" content="Carboxypeptidase A1" /><meta name="citation_keywords" content="Chymotrypsin-C" /><meta name="citation_keywords" content="Claudin-2" /><meta name="citation_keywords" content="Cystic fibrosis transmembrane conductance regulator" /><meta name="citation_keywords" content="E3 ubiquitin-protein ligase UBR1" /><meta name="citation_keywords" content="Extracellular calcium-sensing receptor" /><meta name="citation_keywords" content="Glutathione hydrolase 1 proenzyme" /><meta name="citation_keywords" content="Ribosome maturation protein SBDS" /><meta name="citation_keywords" content="Serine protease inhibitor Kazal-type 1" /><meta name="citation_keywords" content="Trypsin-1" /><meta name="citation_keywords" content="CASR" /><meta name="citation_keywords" content="CEL" /><meta name="citation_keywords" content="CFTR" /><meta name="citation_keywords" content="CLDN2" /><meta name="citation_keywords" content="CPA1" /><meta name="citation_keywords" content="CTRC" /><meta name="citation_keywords" content="GGT1" /><meta name="citation_keywords" content="PRSS1" /><meta name="citation_keywords" content="SBDS" /><meta name="citation_keywords" content="SPINK1" /><meta name="citation_keywords" content="UBR1" /><meta name="citation_keywords" content="Pancreatitis Overview" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Pancreatitis Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Jessica LaRusch" /><meta name="DC.Contributor" content="Sheila Solomon" /><meta name="DC.Contributor" content="David C Whitcomb" /><meta name="DC.Date" content="2014/03/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK190101/" /><meta name="description" content="Pancreatitis is inflammation of the pancreas that progresses from acute (sudden onset; duration &lt;6 months) to recurrent acute (&gt;1 episode of acute pancreatitis) to chronic (duration &gt;6 months). The range of symptoms and disease course vary from person to person." /><meta name="og:title" content="Pancreatitis Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="Pancreatitis is inflammation of the pancreas that progresses from acute (sudden onset; duration &lt;6 months) to recurrent acute (&gt;1 episode of acute pancreatitis) to chronic (duration &gt;6 months). The range of symptoms and disease course vary from person to person." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK190101/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/pancreatitis-ov/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK190101/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D8D65E04180B100000000089F0335.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK190101_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK190101_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/phs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pkan/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK190101_"><span class="title" itemprop="name">Pancreatitis Overview</span></h1><p class="contrib-group"><span itemprop="author">Jessica LaRusch</span>, PhD, <span itemprop="author">Sheila Solomon</span>, MS, CGC, and <span itemprop="author">David C Whitcomb</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK190101_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK190101_ai__"><div class="contrib half_rhythm"><span itemprop="author">Jessica LaRusch</span>, PhD<div class="affiliation small">Department of Medicine<br />Division of Gastroenterology, Hepatology, and Nutrition<br />University of Pittsburgh<br />Pittsburgh, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmpu@jhcsural" class="oemail">ude.cmpu@jhcsural</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sheila Solomon</span>, MS, CGC<div class="affiliation small">Genetic Counselor, GeneDx<br />Gaithersburg, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.xdeneg@nomoloss" class="oemail">moc.xdeneg@nomoloss</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David C Whitcomb</span>, MD, PhD<div class="affiliation small">Departments of Medicine, Cell Biology &#x00026; Physiology, and Human Genetics<br />Division of Gastroenterology, Hepatology, and Nutrition<br />University of Pittsburgh &#x00026; University of Pittsburgh Medical Center<br />Pittsburgh, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ttip@bmoctihw" class="oemail">ude.ttip@bmoctihw</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 13, 2014</span>.</p><p><em>Estimated reading time: 35 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="pancreatitis-ov.Summary" itemprop="description"><h2 id="_pancreatitis-ov_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Pancreatitis is inflammation of the pancreas that progresses from acute (sudden onset; duration &#x0003c;6 months) to recurrent acute (&#x0003e;1 episode of acute pancreatitis) to chronic (duration &#x0003e;6 months). The range of symptoms and disease course vary from person to person.</p><ul><li class="half_rhythm"><div>Familial pancreatitis, defined as pancreatitis from any cause that occurs in a family with an incidence that is greater than would be expected by chance alone, can be non-genetic or genetic, the latter including <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hereditary pancreatitis and pancreatitis syndromes characterized by pancreatitis or pancreatic insufficiency. The majority of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pancreatitis appears to have a complex, multigenic, or <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-environmental etiology with a variable number of <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in genes that affect trypsin regulation, including <i>CASR, CTRC,</i> and <i>CLDN2</i>.</div></li><li class="half_rhythm"><div>Hereditary pancreatitis (HP) is defined as either two or more individuals with pancreatitis in two or more generations of a family (i.e., an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pattern of inheritance) or pancreatitis associated with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>PRSS1</i> disease-causing <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variant. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of hereditary pancreatitis is increased susceptibility to acute pancreatitis, with complications such as chronic inflammation, fibrosis, and chronic pain in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Heterozygous pathogenic variants in <i>PRSS1</i> are found in 60%-100% of families with hereditary pancreatitis, and most large families with pancreatitis spanning multiple generations; <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SPINK1</i> or biallelic pathogenic variants in <i>CFTR</i> result in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> pancreatitis. Syndromes in which pancreatitis is a finding include: Pearson marrow pancreas syndrome, CEL maturity-onset diabetes of the young (<i>CEL</i>-MODY), and Johanson-Blizzard syndrome. Shwachman-Diamond syndrome, an autosomal recessive disorder, includes pancreatic exocrine insufficiency as well as other features.</div></li><li class="half_rhythm"><div>Idiopathic <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> pancreatitis is a single occurrence of pancreatitis in a family for which no etiology is identified.</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Establishing the diagnosis and cause of hereditary pancreatitis relies on medical history, family history, and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, which can be either single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (monogenic) testing or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>. Although a multigene panel that includes <i>PRSS1</i> along with <i>SPINK1</i>, <i>CFTR</i>, and <i>CTRC</i> may be considered, it should be noted that (1) the presence of isolated pathogenic variants in the latter three genes is insufficient to cause pancreatitis and (2) many variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> are likely to be identified.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Hereditary pancreatitis can occur as part of a rare genetic syndrome or as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding. The risk to family members depends on the underlying etiology. Pathogenic variants associated with an increased risk for pancreatitis as an isolated finding may be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, or multigene manner; such pathogenic variants may be classified as disease causing, conferring susceptibility, or disease modifiers.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Management for hereditary pancreatitis is currently similar to that for non-hereditary pancreatitis. Treatment of acute pancreatitis usually focuses on pain management and discontinuation of smoking and alcohol use to slow the rate of progression and to decrease the likelihood of complications, including pancreatic cancer. Treatment of chronic pancreatitis focuses on improving quality of life by managing pancreatic pain, maldigestion, and diabetes mellitus. Total pancreatectomy with islet autotransplantation (TPIAT) should be used only as a last resort to manage patients with severe manifestations of pancreatitis.</p><p><i>Prevention of primary manifestations:</i> The ability to prevent the primary manifestations of hereditary pancreatitis (regardless of genetic cause) is limited.</p><p>The following recommendations (beginning in early childhood) for individuals with (or at risk for) hereditary pancreatitis can help prevent attacks of acute pancreatitis: Low-fat diet, multiple small meals, good hydration, antioxidants, and cessation/abstinence from smoking and alcohol use.</p><p><i>Agents/circumstances to avoid:</i> Alcohol and tobacco use, dehydration, and physical and emotional stresses</p><p><i>Evaluation of relatives at risk:</i> It is recommended that relatives at risk for <i>PRSS1</i>-related hereditary pancreatitis be offered <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the family-specific <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to allow early diagnosis, prevention, and management of symptoms</p></div></div><div id="pancreatitis-ov.Definitions"><h2 id="_pancreatitis-ov_Definitions_">Definitions</h2><p><b>Pancreatitis</b> is characterized by inflammation of the pancreas that progresses from acute (sudden onset; duration &#x0003c;6 months) to recurrent acute (&#x0003e;1 episode of acute pancreatitis) to chronic (duration &#x0003e;6 months). The range of symptoms and disease course vary from person to person.</p><p><b>Acute pancreatitis</b> is diagnosed in the presence of two of the following three findings [<a class="bk_pop" href="#pancreatitis-ov.REF.banks.2006.2379">Banks et al 2006</a>]:</p><ul><li class="half_rhythm"><div>Sudden onset of typical epigastric abdominal pain</div></li><li class="half_rhythm"><div>Elevation of serum amylase or lipase more than three times the upper limits of normal [<a class="bk_pop" href="#pancreatitis-ov.REF.neoptolemos.2000.1955">Neoptolemos et al 2000</a>]</div></li><li class="half_rhythm"><div>Characteristic findings of acute pancreatitis such as pancreatic edema, fat stranding, peripancreatic fluid collections on abdominal imaging [<a class="bk_pop" href="#pancreatitis-ov.REF.o_connor.2011.w2215">O&#x02019;Connor et al 2011</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.banks.2013.102">Banks et al 2013</a>]</div></li></ul><p>Manifestations of acute pancreatitis can range from vague abdominal pain lasting one to three days to severe abdominal pain, systemic inflammation, and multi-organ failure lasting days to weeks and requiring hospitalization with care in an intensive care unit.</p><p>Continued injury increases fibrosis and advances the clinical manifestations from acute pancreatitis to chronic pancreatitis.</p><p><b>Chronic pancreatitis</b> is a continuing inflammatory disease of the pancreas characterized by irreversible morphologic changes that typically cause pain and/or permanent loss of function [<a class="bk_pop" href="#pancreatitis-ov.REF.etemad.2001.682">Etemad &#x00026; Whitcomb 2001</a>]. Chronic pancreatitis is a syndrome of various disorders causing pancreatic inflammation lasting more than six months with irreversible pancreatic changes documented by one of the following:</p><ul><li class="half_rhythm"><div>Abdominal imaging (inflammatory masses; pancreatic parenchyma and ductal calcifications; pseudocysts)</div></li><li class="half_rhythm"><div>Functional studies (pancreatic exocrine insufficiency with maldigestion of food; pancreatic endocrine insufficiency with diabetes mellitus with destruction of the islets [type 3c])</div></li><li class="half_rhythm"><div>Histologic changes (atrophy, fibrosis, and/or sclerosis)</div></li></ul><p>Chronic pancreatitis typically manifests as episodic or continuous mild to severe abdominal pain, and progresses to exocrine pancreatic insufficiency leading to maldigestion and/or pancreatic endocrine insufficiency (glucose intolerance progressing to diabetes mellitus type 3c).</p><p>Pain, the primary complaint of persons with chronic pancreatitis, originates in the abdomen in response to pancreatic injury. Pain character, frequency, and severity are highly variable due to multiple causes. As the disease progresses pain may convert to constant neuropathic pain, which is not controlled even by major interventions such as spinal block or total pancreatectomy.</p><p>Pancreatic cancer risk is increased after age 50 years in those with long-standing chronic inflammation of the pancreas. Persons with hereditary pancreatitis are at high risk because their onset of chronic pancreatitis is 20-30 years earlier than in <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> forms of chronic pancreatitis. Although earlier studies estimated life-time risk of pancreatic cancer at nearly 40%, this was in populations with high rates of smoking. For non-smokers the lifetime risk may be below 20% [<a class="bk_pop" href="#pancreatitis-ov.REF.rebours.2008.111">Rebours et al 2008</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.rebours.2009.97">Rebours et al 2009</a>].</p><p><b>Familial pancreatitis</b> is defined as pancreatitis from any cause that occurs in a family with an incidence that is greater than would be expected by chance alone, given the size of the family and the incidence of pancreatitis within a defined population. Familial pancreatitis can have a genetic and/or a non-genetic etiology; thus, <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pancreatitis includes <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hereditary pancreatitis (with or without an identified <a href="/books/n/gene/prss1-hp/"><i>PRSS1</i> pathogenic variant</a>) as well as pancreatitis syndromes characterized by pancreatitis or pancreatic insufficiency.</p><p><b>Hereditary pancreatitis</b> (HP) is defined as EITHER two or more individuals with pancreatitis in two or more generations of a family (i.e., an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pattern of inheritance) OR pancreatitis associated with a known <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#pancreatitis-ov.REF.whitcomb.2010">Whitcomb &#x00026; Lowe 2010</a>].</p><p><b>Idiopathic <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> pancreatitis.</b> An individual with no family history of pancreatitis is referred to as a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence of pancreatitis in a family). Pancreatitis in a simplex case may be due to environmental, metabolic, or genetic causes (e.g., <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance). If no etiology is identified in a simplex case, the pancreatitis is considered to be <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> sporadic pancreatitis.</p></div><div id="pancreatitis-ov.Causes_of_Hereditary_Pan"><h2 id="_pancreatitis-ov_Causes_of_Hereditary_Pan_">Causes of Hereditary Pancreatitis</h2><p>Hereditary pancreatitis (HP), a disease of recurrent injury to the pancreas, is most often caused by abnormal regulation of trypsin, the master regulator of pancreatic digestive enzyme activation. In HP, inflammation is initiated by injury to the pancreas secondary to <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in genes that affect trypsin regulation [<a class="bk_pop" href="#pancreatitis-ov.REF.whitcomb.1999.253">Whitcomb &#x00026; Ulrich 1999</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.yadav.2010.131">Yadav &#x00026; Whitcomb 2010</a>].</p><p>Under acinar cell stress (e.g., hyperstimulation, intracellular hypercalcemia), intracellular trypsinogen is likely converted to trypsin, which activates other digestive enzymes causing injury. Injury releases immune system-activating molecules that cause an initial acute inflammatory response, followed by recruitment of tissue macrophages and activated pancreatic stellate cells. Recurrent injury leads to chronic pancreatitis and fibrosis, mediated by pancreatic stellate cells.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of HP is increased susceptibility to acute pancreatitis, with secondary features of chronic pancreatitis (including pancreatic fibrosis, chronic pain, maldigestion and diabetes mellitus [Type 3c]) occurring in at least 50%. The risk of pancreatic cancer risk is also increased; the life-time risk of pancreatic cancer in non-smokers and families without a strong history of pancreatic cancer is less than 20%.</p><div id="pancreatitis-ov.Genes_in_which_Pathogeni"><h3>Genes in which Pathogenic Variants are Associated with Hereditary Pancreatitis</h3><p><b><i>PRSS1</i>.</b> A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <i>PRSS1</i>, which results in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance of pancreatitis, is found in 60%-100% of families with hereditary pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.larusch.2011.467">LaRusch &#x00026; Whitcomb 2011</a>] (see <a href="/books/n/gene/prss1-hp/"><i>PRSS1</i>-Related Hereditary Pancreatitis</a>).</p><p>Although the clinical manifestations of <i>PRSS1-</i>related hereditary pancreatitis and non-<i>PRSS1</i>-related HP are not significantly different, the typical age of onset of non-<i>PRSS1</i>-related HP is later than that of <i>PRSS1</i>-related HP (which is ~10 years).</p><p><i>PRSS1</i> encodes trypsin-1 (cationic trypsinogen) a major pancreatic digestive enzyme that also catalyzes activation of other pancreatic zymogens to active enzymes, a process that normally occurs in the intestine. HP-causing <i>PRSS1</i> pathogenic variants typically result in a trypsin protein that is either prematurely activated or resistant to degradation. Note that <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>PRSS1</i> (resulting in a presumed 50% or greater increase of baseline trypsin protein) also causes HP, but may be under-recognized because such variants are not always identified by clinical testing [<a class="bk_pop" href="#pancreatitis-ov.REF.chen.2008.102">Chen et al 2008</a>; <a class="bk_pop" href="#pancreatitis-ov.REF.masson.2008c.521">Masson et al 2008c</a>; <a class="bk_pop" href="#pancreatitis-ov.REF.larusch.2012.258">LaRusch et al 2012</a>; Author, personal observation].</p><p><b><i>SPINK1</i>.</b> Pathogenic variants in <i>SPINK1,</i> encoding serine protease inhibitor, Kazel-type 1, can lead to <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> pancreatitis.</p><p>In the United States, Europe, and India a high-risk haplotype containing <i>SPINK1</i> p.Asn34Ser (<a href="/nuccore/NM_003122.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003122.3</a>:c.101A&#x0003e;G) is common, with a minor <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> as high as 3%.</p><p>In China, Japan, and Korea the <i>SPINK1</i> splice variant (c.194+2T&#x0003e;C, also known as IVS3+2T&#x0003e;C) is common.</p><p>SPINK1 serves as a trypsin inhibitor that is upregulated by inflammation (an acute phase protein). Since <i>SPINK1</i> encodes a protein that guards the pancreas from the effects of recurrent or persistent trypsin activation, it is not a typical susceptibility <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for acute pancreatitis, but rather a susceptibility gene for the chronic pancreatitis that follows acute pancreatitis. It is not known if <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SPINK1</i> pathogenic variants alone are sufficient to cause recurrent acute or chronic pancreatitis, but multiple families with biallelic <i>SPINK1</i> pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members have been documented. (See <i>SPINK1</i> discussion related to <a href="#pancreatitis-ov.Complex_Multigenic_Disor">complex genotypes</a>.)</p><p><b><i>CFTR</i>.</b> Pathogenic variants in <i>CFTR</i>, encoding the cystic fibrosis transmembrane conductance protein, are associated with recurrent acute and chronic pancreatitis. Indeed, CF is defined (and the severity of <i>CFTR</i> variants estimated) by the effect of variants on the pancreas. CFTR is the most important molecule for fluid secretion in the pancreatic duct cell. The primary function of duct cells is to secrete a bicarbonate-rich fluid that flushes the zymogens out of the pancreas into the duodenum. Dysfunction of CFTR results in retention of zymogens in the duct where they can become active and begin digesting the surrounding pancreas, leading to acute pancreatitis.</p><p>The features of <i>CFTR</i>-associated diseases depend on the functional consequences of specific pathogenic variants on the two <i>CFTR</i> alleles, as well as variants in modifier genes and effects of environmental factors. <a href="/books/n/gene/cf/">Cystic fibrosis</a> is caused by two severe pathogenic variants (<i>CFTR<sup>sev</sup></i>). Recent data suggest that <i>CFTR</i> pathogenic variants that affect bicarbonate conductance while maintaining chloride conductance (e.g., p.Arg75Gln (<a href="/nuccore/NM_000492.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000492.3</a>:c.224G&#x0003e;A) have major effects on the pancreas but minimal effects on the lungs since the pancreas uses CFTR as a bicarbonate channel [<a class="bk_pop" href="#pancreatitis-ov.REF.schneider.2011.162">Schneider et al 2011</a>]. The functional effect of <i>CFTR</i> genotypes is determined by the least severe <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; thus, either two bicarbonate-defective (BD) variants (<i>CFTR<sup>BD</sup></i> / <i>CFTR<sup>BD</sup></i>) or one BD and one severe variant (<i>CFTR<sup>BD</sup></i> / <i>CFTR<sup>sev</sup></i>) can result in a monogenic pancreatitis-predominant disorder.</p></div><div id="pancreatitis-ov.Syndromes_that_Include_P"><h3>Syndromes that Include Pancreatitis or Pancreatic Insufficiency</h3><p>Pathogenic variants in several genes are associated with rare disorders in which pancreatitis or pancreatic insufficiency is part of their complex <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#pancreatitis-ov.REF.durie.1996.169">Durie 1996</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.lerch.2006.219">Lerch et al 2006</a>].</p><p><b><i>SBDS</i>.</b>
<a href="/books/n/gene/sds/">Shwachman-Diamond syndrome</a> (SDS) is a rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SBDS</i> pathogenic variants, which appear to affect RNA function. Clinical features include short stature, skeletal abnormalities, exocrine pancreatic insufficiency, and hematologic dysfunction resulting in multiple infections and risk of myeloid leukemias [<a class="bk_pop" href="#pancreatitis-ov.REF.boocock.2003.97">Boocock et al 2003</a>].</p><p><a href="/books/n/gene/kss/"><b>Mitochondrial (mt) DNA deletions</b></a><b>.</b> Pearson marrow pancreas syndrome is a severe disorder caused by deletions of mtDNA resulting in defective oxidative phosphorylation. Clinical features involve the hematopoietic system with severe, transfusion-dependent macrocytic anemia, exocrine pancreas dysfunction with features of chronic pancreatitis, and liver and kidney dysfunction [<a class="bk_pop" href="#pancreatitis-ov.REF.r_tig.1990.1601">R&#x000f6;tig et al 1990</a>]. Diabetes mellitus and adrenal dysfunction can also be observed [<a class="bk_pop" href="#pancreatitis-ov.REF.hopewell.1990.760">Hopewell et al 1990</a>]. Children who survive develop features of <a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a>, an encephalomyopathy with ophthalmoplegia, retinal degeneration, ataxia, and endocrine abnormalities [<a class="bk_pop" href="#pancreatitis-ov.REF.becher.1999.577">Becher et al 1999</a>].</p><p><b><i>CEL</i>.</b> Pathogenic variants and tandem repeat variants in <i>CEL</i>, encoding carboxyl ester lipase, are associated with both pancreatic exocrine, endocrine dysfunction, and chronic pancreatitis in a syndrome referred to as <i>CEL</i>-maturity onset diabetes of the young (<i>CEL</i>-MODY) (see <a href="/books/n/gene/mody-ov/">MODY Overview</a>) This disorder presents with diabetes mellitus, pancreatic lipomatosis, and exocrine dysfunction without the severe malnutrition seen in <a href="/books/n/gene/cf/">cystic fibrosis</a>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> [<a class="bk_pop" href="#pancreatitis-ov.REF.raeder.2006.54">Raeder et al 2006</a>]. It is managed as other types of diabetes mellitus and pancreatic dysfunction.</p><p><b><i>UBR1</i>.</b> Johanson-Blizzard syndrome (OMIM <a href="http://omim.org/entry/243800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">243800</a>) is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder that includes <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> exocrine pancreatic inflammation and insufficiency, multiple malformations such as nasal wing aplasia, and (frequently) intellectual disability [<a class="bk_pop" href="#pancreatitis-ov.REF.zenker.2005.1345">Zenker et al 2005</a>]. The disorder is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>UBR1</i> (a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> involved in protein synthesis) that result in either loss of gene expression or expression of a nonfunctional <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</p></div><div id="pancreatitis-ov.Complex_Multigenic_Disor"><h3>Complex Multigenic Disorders</h3><p>The majority of kindreds with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pancreatitis without risk associated with a single <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> (e.g., <i>PRSS1</i>, <i>CFTR</i>, or <i>SPINK1)</i> are small, with two to four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. These families and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) are increasingly found to have complex, multigenic, or <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-environmental disorders with a variable number of <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in genes that affect trypsin regulation.</p><p>Recently, research studies suggest that at least one third of recurrent acute and chronic pancreatitis results from complex genetic mechanisms [Whitcomb, NAPS2 study 2014, unpublished]. Although the most common genotypes are complex <i>SPINK1/CFTR</i> variants, a growing list of common, low-risk variants are now recognized as being significant contributors to pancreatic disease. The paradigm appears to be a combination of a variant in a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that increases the risk of recurrent trypsin activation (e.g., <i>PRSS1</i>, <i>CFTR</i>) plus a variant in a gene that protects the pancreas from active trypsin or chronic inflammation (e.g., <i>SPINK1</i>).</p><p>In rare instances families with apparent <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance do not have an identified <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In one such family, multiple pathogenic variants in <i>PRSS1, SPINK1</i>, and <i>CFTR</i> were identified in different combinations in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members [<a class="bk_pop" href="#pancreatitis-ov.REF.larusch.2012.258">LaRusch et al 2012</a>].</p><p>The traditional method of determining the effect of the second class of genes in complex multigenic disorders is calculation of an odds ratio, which reflects the frequency of the variant in the disorder divided by the frequency of the variant in the population. However, in order for a variant to be detected as a disease modifier (e.g., one that worsens the severity of recurrent trypsin activation), the variant must be <i>common</i> within the population so that the co-inheritance of injury-causing pathogenic variants and defective-protection pathogenic variants is also common. Thus, the importance and effect of these variants is not accurately reflected by an odds ratio, but rather by the likelihood that the disease will progress from recurrent mild injury to end-stage disease.</p><p>Other genes in which variants have been considered as possible modifiers include the following.</p><p><b><i>CASR</i></b> encodes the calcium sensing receptor (CASR), a plasma membrane receptor that senses calcium levels outside the cell and then activates a variety of regulator actions inside the cell. Although first identified in the parathyroid gland in &#x0201c;calcium syndromes&#x0201d; caused by <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> or <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variants [<a class="bk_pop" href="#pancreatitis-ov.REF.pidasheva.2004.107">Pidasheva et al 2004</a>], this receptor is now known to be used throughout the body by different cells in different ways:</p><ul><li class="half_rhythm"><div>Loss-of-function <i>CASR</i> pathogenic variants are commonly seen in the pancreas with <i>CFTR</i> pathogenic variants, suggesting that a failure to detect elevated calcium levels in the pancreatic duct triggers CFTR channel opening and duct flushing.</div></li><li class="half_rhythm"><div>Gain-of-function pathogenic variants are linked with alcoholic pancreatitis, suggesting that <i>CASR</i> pathogenic variants on the acinar cell are linked to intracellular hypercalcemia in combination with the effects of alcohol on calcium regulation [<a class="bk_pop" href="#pancreatitis-ov.REF.larusch.2011.467">LaRusch &#x00026; Whitcomb 2011</a>].</div></li></ul><p><b><i>CTRC</i></b> encodes chymotrypsin C (CTRC), a low-abundance pancreatic digestive enzyme that is synthesized with PRSS1 [<a class="bk_pop" href="#pancreatitis-ov.REF.beer.2013.1616">Beer et al 2013</a>]. CTRC plays an important role in degrading prematurely activated trypsin within the pancreas. Several studies have associated pathogenic variants in <i>CTRC</i> with chronic pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.masson.2008a.83">Masson et al 2008a</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.rosendahl.2008.78">Rosendahl et al 2008</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.chang.2009.287">Chang et al 2009</a>]. Of note, <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>CTRC</i> pathogenic variants do not appear to cause chronic pancreatitis but rather are seen in combination with other trypsin-activating variants including <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>CFTR</i> or <i>SPINK1</i> variants [<a class="bk_pop" href="#pancreatitis-ov.REF.rosendahl.2013.582">Rosendahl et al 2013</a>].</p><p><b><i>CLDN2</i></b> encodes claudin-2, a tight-junction protein that seals the space between epithelial cells, which differs from most other claudins in that it forms water pores and sodium channels (rather than a true tight junction that is permeable to water or solute). Claudin-2, which is normally expressed in the proximal pancreatic duct, is thought to facilitate the transport of water and sodium into the duct to match the chloride and bicarbonate that are actively secreted by pancreatic duct cells through CFTR. Claudin-2 is dynamically regulated, and expression is upregulated during inflammation.</p><p>The first genome-wide association study (GWAS) to study pancreatitis identified a high-risk <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> near <i>CLDN2</i> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> [<a class="bk_pop" href="#pancreatitis-ov.REF.whitcomb.2012.418">Whitcomb 2012</a>]. The high-risk variant is common with a minor <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> of 0.26 and was strongly associated with alcohol-related chronic pancreatitis rather than recurrent acute pancreatitis. The <i>CLDN2</i>-risk variant is associated with atypical localization of claudin-2 in pancreatic acinar cells. These results could partially explain the high frequency of alcohol-related pancreatitis in men (male hemizygote frequency is 0.26) compared to women (female homozygote frequency is 0.07). Nearly half of all men with a diagnosis of alcoholic pancreatitis have the high-risk <i>CLDN2</i> variant.</p><p><b><i>CPA1</i></b> encodes carboxypeptidase A1, the second most abundant pancreatic digestive enzyme protein after trypsinogen, contributing up to 10% of the total secreted protein. Mutation of <i>CPA1</i> is associated with nonalcoholic chronic pancreatitis, especially with an early age of onset [<a class="bk_pop" href="#pancreatitis-ov.REF.witt.2013.1216">Witt et al 2013</a>]. Risk for chronic pancreatitis (which is unrelated to trypsin activation) appears to be related to endoplasmic reticulum stress from pathogenic variants that alter protein folding, triggering the unfolded protein response. Sequence analysis of all ten <i>CPA1</i> exons in 944 cases from Germany and 3,938 controls revealed 35 different pathogenic variants. Functional studies in the laboratory showed that many of the variants had less than 20% of expected activity and were not secreted from experimental cells, suggesting that the mutated peptides were misfolding, causing stress inside the endoplasmic reticulum. The low-activity mutated proteins were found in 3.1% of cases compared to 0.1% of controls (OR = 25). The finding, which was replicated in three other groups, was especially prevalent in children with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> chronic pancreatitis.</p><p>See <a href="/books/NBK190101/bin/pancreatitis-ov-gen_risk_factors.pdf">Genetic Risk Factors that Predispose to Pancreatitis</a> (pdf) for additional information regarding genetic risk factors that predispose to pancreatitis; Tables 1-5 summarize some of the most common variants (and their phenotypic consequences) that may either cause HP or contribute to multigenic inheritance.</p></div><div id="pancreatitis-ov.Familial_Pancreatitis_of"><h3>Familial Pancreatitis of Unknown Cause</h3><p>In 60% of families with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pancreatitis in which no <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, the genetic cause is as yet unknown.</p><p>Possible explanations for failure to identify a genetic cause to date:</p><ul><li class="half_rhythm"><div><b>&#x0201c;Missed&#x0201d; risk factors.</b> Some genetic risk factors were not identified by testing methods used in the past. For example, <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> panels or variant screening that may miss rare or <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a> pathogenic variants; classic sequencing techniques that may miss deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> pathogenic variants (e.g., <i>CFTR</i> c.3717+12191C&#x0003e;T) and copy number variants (e.g., <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>). Massively parallel sequencing approaches may help to identify rare or private pathogenic variants as well as provide the opportunity to identify variants in newly identified risk genes.</div></li><li class="half_rhythm"><div><b>Unknown genetic risk factors.</b> Even when correcting for potentially &#x0201c;missed&#x0201d; pathogenic variants, it is likely that there are pathogenic variants in genes that have not been discovered. While <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> technologies are expanding to include copy number analysis and full <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> sequencing, a substantial effort is also being made to identify novel risk factors in pancreatitis. Techniques such as analysis of large genome-wide association studies (GWAS) [<a class="bk_pop" href="#pancreatitis-ov.REF.whitcomb.2012.1349">Whitcomb et al 2012</a>] and massively parallel <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a>/<a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> [<a class="bk_pop" href="#pancreatitis-ov.REF.larusch.2012.258">LaRusch et al 2012</a>] are now being applied with the goal of identifying novel risk factors for HP.</div></li><li class="half_rhythm"><div><b>Phenocopies.</b> Instances in which environmental factors mimic known genetic diseases are likely to be rare for a multigenerational family not living together. As environmental toxicity is a known etiology for pancreatitis, the possibility of a phenocopy mimicking <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pancreatitis cannot be completely ruled out [<a class="bk_pop" href="#pancreatitis-ov.REF.khurana.2001.102">Khurana &#x00026; Barkin 2001</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.nitsche.2012.131">Nitsche et al 2012</a>].</div></li></ul></div></div><div id="pancreatitis-ov.Establishing_the_Diagnos"><h2 id="_pancreatitis-ov_Establishing_the_Diagnos_">Establishing the Diagnosis and Cause of Hereditary Pancreatitis in a Proband</h2><p>The clinical findings, morphologic features, and laboratory findings of hereditary pancreatitis are the same as those of alcohol-related chronic pancreatitis; thus, establishing the diagnosis and cause of hereditary pancreatitis relies on medical history, family history, and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Of note, establishing the cause of HP informs <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> counseling for family members and may inform future therapeutic options.</p><div id="pancreatitis-ov.Medical_History"><h3>Medical History</h3><p>Attention should be paid to: unexplained documented episode(s) of acute pancreatitis in childhood; recurrent acute attacks of pancreatitis of unknown cause; evidence for chronic pancreatitis; and history of alcohol use and tobacco smoking. In addition, the medical history should include signs and symptoms of pancreatitis-associated syndromes such as <a href="/books/n/gene/cf/">cystic fibrosis</a> (CF), atypical CF, or <a href="/books/n/gene/sds/">Shwachman-Diamond syndrome</a> (SDS).</p><p>The medical history may be able to exclude alternate etiologies of pancreatitis, such as biliary pancreatitis, hyperlipidemia, autoimmune disorders, obstructive pancreatitis, medications, infections, or cystic fibrosis (see <a href="/books/n/gene/cf/"><i>CFTR</i>-Related Disorders</a>).</p><p>Early-onset pancreatitis (age &#x0003c;30 years) is often indicative of pancreatitis with an underlying genetic etiology (i.e., an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or multiple complex pathogenic variants) [<a class="bk_pop" href="#pancreatitis-ov.REF.pf_tzer.2000.615">Pf&#x000fc;tzer et al 2000</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.lee.2011.478">Lee et al 2011</a>], whereas late-onset pancreatitis may indicate a complex pathology with both genetic and environmental causes.</p></div><div id="pancreatitis-ov.Family_History"><h3>Family History</h3><p>The presence in a family of two or more individuals with pancreatitis in two or more generations raises the suspicion of hereditary pancreatitis; it is appropriate to obtain a three-generation family history with attention to other relatives with signs and symptoms of acute or chronic pancreatitis.</p><p>Documentation of relevant findings in relatives can be accomplished through review of their medical records including the results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, laboratory testing, imaging studies, and operative reports. Furthermore, it is prudent to determine if any relatives have the diagnosis of cystic fibrosis (see <a href="/books/n/gene/cf/"><i>CFTR</i>-Related Disorders</a>).</p><p>Note: Ongoing and high levels of alcohol and tobacco use in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members may indicate an alcohol-related etiology, but there is demonstrated genetic risk involved with substantial overlap with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> pancreatitis, such that excessive alcohol use does not exclude consideration of genetic causes of pancreatitis.</p></div><div id="pancreatitis-ov.Molecular_Genetic_Testin"><h3>Molecular Genetic Testing</h3><p>Molecular genetic testing is indicated in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with pancreatitis and at least one of the following:</p><ul><li class="half_rhythm"><div>An unexplained documented episode of acute pancreatitis in childhood</div></li><li class="half_rhythm"><div>Recurrent acute attacks of pancreatitis of unknown cause</div></li><li class="half_rhythm"><div>Chronic pancreatitis of unknown cause, particularly with onset before age 25 years</div></li><li class="half_rhythm"><div>A history of at least one relative with recurrent acute pancreatitis, chronic pancreatitis of unknown cause, or childhood pancreatitis of unknown cause</div></li></ul><p>Note: Although genetic testing techniques have advanced and additional genetic risk factors have been identified in the last ten years, the issues of privacy, consent, and clinical suitability for genetic testing for hereditary pancreatitis have not significantly changed; thus, the original consensus document [<a class="bk_pop" href="#pancreatitis-ov.REF.ellis.2001.405">Ellis et al 2001</a>] is still applicable and guidelines are reflected in this <i>GeneReview</i> [<a class="bk_pop" href="#pancreatitis-ov.REF.ellis.2004.839">Ellis 2004</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.solomon.2012.112">Solomon &#x00026; Whitcomb 2012</a>].</p><p>The established guidelines for genetic testing for pancreatic diseases focus on the monogenic, classic Mendelian approach; in the future, however, when the complex genetics of pancreatic disease and the role of variants in modifier genes are better understood and the cost of <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> technology decreases, the recommendations will need updating.</p><div id="pancreatitis-ov.Approach_1_SingleGene_Te"><h4>Approach 1: Single-Gene Testing for Familial Pancreatitis with an Autosomal Dominant Inheritance Pattern</h4><p>Currently it is recommended that <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> be performed to identify a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the most common cause of hereditary pancreatitis (See <a href="/books/n/gene/prss1-hp/"><i>PRSS1</i>- Related Hereditary Pancreatitis</a>.) Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis to detect the known duplication of <i>PRSS1</i> may be appropriate when the evidence of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> HP is strong and no pathogenic variant has been identified by sequence analysis of <i>PRSS1</i> or <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> testing (see <a href="#pancreatitis-ov.Approach_2_Multigene_Pan">Approach 2</a>).</p><p>Of note, <i>PRSS1</i> has very high homology with other trypsinogen genes and pseudogenes, and the pathogenic variants often result from <a class="def" href="/books/n/gene/glossary/def-item/gene-conversion/">gene conversion</a> events between trypsinogen genes or pseudogenes (see <a class="bk_pop" href="#pancreatitis-ov.REF.chen.2000.463">Chen &#x00026; Ferec [2000]</a>). Regardless of the sequencing method employed, primers must be carefully chosen and validated to amplify the fragment for the correct gene and transcript. Thus a multi-step method is required to verify the presence of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRSS1</i> [<a class="bk_pop" href="#pancreatitis-ov.REF.masson.2008b.82">Masson et al 2008b</a>].</p></div><div id="pancreatitis-ov.Approach_2_Multigene_Pan"><h4>Approach 2: Multigene Panels for Familial Pancreatitis with an Autosomal Dominant Inheritance Pattern</h4><p>Use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> comprising <i>PRSS1,</i>
<i>SPINK1</i>, <i>CFTR</i>, and <i>CTRC</i> (and possibly additional genes as they are discovered and understood) may be appropriate. This approach recognizes that:</p><ul><li class="half_rhythm"><div>Multiple genetic risk factors, such as variants in <i>CFTR</i> and <i>SPINK1,</i> are common, and various combinations of these genetic risk factors may be seen in different generations of one family [<a class="bk_pop" href="#pancreatitis-ov.REF.larusch.2012.258">LaRusch et al 2012</a>].</div></li><li class="half_rhythm"><div>The dropping cost of <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> makes the initial simultaneous testing of multiple genes cost-effective compared to the sequential testing of multiple genes, which typically also involves multiple clinical visits and counseling sessions.</div></li></ul><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="pancreatitis-ov.General_Interpretation_o"><h4>General Interpretation of Genetic Test Results</h4><p><b><i>PRSS1</i>.</b> Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> confirms a diagnosis of hereditary pancreatitis, informs treatment, and enables variant-specific testing of at-risk family members. See <a href="/books/n/gene/prss1-hp/"><i>PRSS1</i>-Related Hereditary Pancreatitis</a>.</p><p><b><i>SPINK1, CFTR,</i></b> or <b><i>CTRC</i>.</b> A subset of variants in <i>SPINK1, CFTR</i> and <i>CTRC</i> are known to be pathogenic, and discovery of combinations of these variants is strong evidence of disease association. If the person has one <i>SPINK1, CFTR,</i> or <i>CTRC</i> variant, and it segregates in a family with those with disease, the variant may be pathogenic and associated with another factor.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b><i>SPINK1</i></b> pathogenic variants have been identified in approximately 20% of small families with hereditary pancreatitis who do not have a <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Homozygosity or compound heterozygosity for p.Asn34Ser confers a high risk for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> hereditary pancreatitis (see <a href="#pancreatitis-ov.Genes_in_which_Pathogeni">Genes in which Pathogenic Variants are Associated with Hereditary Pancreatitis</a>, <b><i>SPINK1</i></b>); additionally p.Asn34Ser is associated with early-onset, more aggressive disease in persons with additional pathogenic variants in other genes (see <a href="/books/NBK190101/bin/pancreatitis-ov-suppl_gene_info.pdf">Supplemental Gene Information</a> &#x02013; pdf).</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>CFTR</i></b> pathogenic variants have been identified in approximately 25% of families who do not have a <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. (Note: The frequency of <i>CFTR</i> deletions in hereditary pancreatitis has not been investigated.) For example, the <i>CFTR</i> variant p.Arg75Gln, which predisposes to hereditary pancreatitis by impairing the conductance of bicarbonate rather than chloride, is not associated with lung disease and typical cystic fibrosis [<a class="bk_pop" href="#pancreatitis-ov.REF.schneider.2011.162">Schneider et al 2011</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.rosendahl.2013.582">Rosendahl et al 2013</a>]. However, the odds ratio for p.Arg75Gln is 1.5, the <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> is high in the general population, and the allele is only significant in the presence of a second pathogenic variant as a recessive trait (see <a href="/books/NBK190101/bin/pancreatitis-ov-suppl_gene_info.pdf">Supplemental Gene Information</a>).</div><div class="half_rhythm">Individuals with symptoms of pancreatitis and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>CFTR</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> &#x02013; without a <i>SPINK1, CTRC</i>, or <i>CASR</i> pathogenic variant &#x02013; should be evaluated for additional manifestations of a <i>CFTR</i>-related disorder, such as bronchiectasis, infertility in males, and chronic sinusitis in the event that an undetected second pathogenic <i>CFTR</i> variant is present.</div><div class="half_rhythm">Individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>CFTR</i> pathogenic variants consistent with atypical cystic fibrosis (CF) should be referred to a CF center for formal functional testing (e.g., sweat test) before the diagnosis of cystic fibrosis is confirmed.</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>CTRC</i>.</b> Pathogenic variants identified in a small number of persons with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> chronic pancreatitis are usually linked to another trypsin-activating variant (see <a href="#pancreatitis-ov.Complex_Multigenic_Disor">Complex Multigenic Disorders</a>, <b><i>CTRC</i></b>; <a href="/books/NBK190101/bin/pancreatitis-ov-suppl_gene_info.pdf">Supplemental Gene Information</a>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>CPA1.</i></b> Pathogenic variants are generally amino acid substitutions that cause misfolding, which is difficult to predict without functional studies. See <a class="bk_pop" href="#pancreatitis-ov.REF.witt.2013.1216">Witt et al [2013]</a> for information on specific variants.</div></li></ul><p><b>Other genes.</b> Variants in additional genes recently associated with pancreatitis, in general:</p><ul><li class="half_rhythm"><div>Are relatively low-risk alleles (e.g., odds ratio &#x0003c;2),</div></li><li class="half_rhythm"><div>Have not been identified in independent cohorts, and</div></li><li class="half_rhythm"><div>Do not have functional studies to demonstrate a plausible molecular mechanism.</div></li></ul><p><b>Note:</b> Often, only a single <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPINK1,</i>
<i>CFTR,</i> or <i>CTRC</i> is identified in a family with HP; the variant will generally (but not exclusively) segregate with disease. Although such variants may be a risk factor for HP, additional unidentified modifying factors also contribute to disease. <i>Of note, the majority of individuals with a single pathogenic variant</i>
<i>in these genes do not have pancreatitis.</i></p><p>For further information about <i>SPINK1</i>, <i>CFTR,</i> and <i>CTRC</i> see <a href="/books/NBK190101/bin/pancreatitis-ov-gen_risk_factors.pdf">Genetic Risk Factors that Predispose to Pancreatitis </a> and <a href="/books/NBK190101/bin/pancreatitis-ov-suppl_gene_info.pdf">Supplemental Gene Information</a> (pdfs).</p></div></div></div><div id="pancreatitis-ov.Genetic_Counseling"><h2 id="_pancreatitis-ov_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="pancreatitis-ov.Modes_of_Inheritance"><h3>Modes of Inheritance</h3><p>Acute and chronic pancreatitis may present as part of a syndrome or as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> finding.</p><div id="pancreatitis-ov.Syndromic_Pancreatitis"><h4>Syndromic Pancreatitis</h4><p>Mode of inheritance and <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> counseling are determined by the specific syndrome identified (<a href="/books/n/gene/lpl/">familial lipoprotein lipase deficiency</a>, <a href="/books/n/gene/citrin/">citrin deficiency</a>, <a href="/books/n/gene/cf/">cystic fibrosis</a>, <a href="/books/n/gene/mma/">methylmalonic acidemia</a>, <a href="/books/n/gene/propionic-a/">propionic acidemia</a>, <a href="/books/n/gene/cach/">childhood ataxia with central nervous system hypomyelination/vanishing white matter disease</a>, <a href="/books/n/gene/wilson/">Wilson disease</a>, <a href="/books/n/gene/fap/">familial adenomatous polyposis</a>, <a href="/books/n/gene/dmn/">permanent neonatal diabetes mellitus</a>, <a href="/books/n/gene/sds/">Schwachman-Diamond syndrome</a>, <a href="/books/n/gene/alagille/">Alagille syndrome</a>).</p></div><div id="pancreatitis-ov.Isolated_Pancreatitis"><h4>Isolated Pancreatitis</h4><p>Variants associated with increased risk of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> pancreatitis may be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, or multigene manner; such variants may be classified as pathogenic (disease causing), conferring susceptibility, or disease modifiers. In those with <i>PRSS1</i> allelic variants, pancreatitis may appear to be <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> because of non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, adoption, or paternity issues; in those with allelic variants in <i>CFTR, SPINK1, CTRC</i>, and other genes pancreatitis may appear to be sporadic because of small family size, chance, or non-penetrance in sibs.</p><p>For all situations, genetic testing can only determine if a person has or has not inherited a variant that confers high risk for disease. Genetic testing cannot determine if the individual will develop disease, the age of disease onset, or disease severity.</p><p>The assessment of risk to family members of developing pancreatitis depends on several variables: genetic risk factors, smoking, alcohol use, gender, and developmental differences such as pancreas divisum (incomplete pancreatic duct development resulting in two duct systems rather than one, with most of the pancreas draining through a high-resistance papilla), as well as unknown environmental and genetic risk factors. Thus, risk assessment needs to be tailored to each individual and his/her family.</p><p><b>Autosomal dominant inheritance.</b>
<a href="/books/n/gene/prss1-hp/"><i>PRSS1</i>-related hereditary pancreatitis</a> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p><b>Autosomal recessive inheritance.</b> Pancreatitis caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CTRC, CFTR, or SPINK1</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Digenic inheritance.</b> Pancreatitis caused by double heterozygosity (i.e., presence of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> at each of two separate genetic loci) is inherited in a <a class="def" href="/books/n/gene/glossary/def-item/digenic/">digenic</a> manner.</p><p><b>Multigene inheritance.</b> Identification of multiple risk variants in any combination of the pancreatitis-associated genes indicates complex disease; <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> should be handled on a case-by-case basis. Specific combinations of genetic factors may be epistatic, while others are additive. No systematic approach is available to predict the effects of most of these complex genotypes.</p><p>The severity of disease and prognosis depends on the number of variants and the relationship of the specific variants to disease causation, as well as environmental and stochastic factors; however, multigenic pancreatitis is unlikely to be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> fashion.</p><p><b>Single variant.</b> A single variant in <i>CTRC, CFTR, or SPINK1</i> may be the only identified <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a kindred with apparent hereditary pancreatitis, segregates exclusively with disease, and contribute to the disease manifestations in the family. However, because the vast majority of individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a pathogenic variant in one of these known pancreatitis-related genes are healthy, disease pathogenesis is likely due to additional unknown factors.</p><p>For families in which a known <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not identified, additional risk information cannot be provided.</p></div></div><div id="pancreatitis-ov.Related_Genetic_Counseli"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#pancreatitis-ov.Evaluation_of_Relatives">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="pancreatitis-ov.Prenatal_Testing_and_Pre"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for hereditary pancreatitis are possible.</p><p>Note: The reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and inability to predict the natural disease course or severity of disease based on a genetic test result generally makes interpretation of prenatal testing indeterminate.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="pancreatitis-ov.Resources"><h2 id="_pancreatitis-ov_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Pancreas Foundation (NPF)</b></div><div>101 Federal Street</div><div>Suite 1900</div><div>Boston MA 02210</div><div><b>Phone:</b> 866-726-2737 (toll-free); 617-342-7019</div><div><b>Fax:</b> 617-342-7080</div><div><b>Email:</b> info@pancreasfoundation.org</div><div><a href="http://www.pancreasfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pancreasfoundation.org</a></div></li><li class="half_rhythm"><div><b>Pancreatica.org</b></div><div>149 Bonifacio Place</div><div>Monterey CA 93940</div><div><b>Phone:</b> 831-658-0600</div><div><b>Email:</b> webmaster@pancreatica.org</div><div><a href="http://www.pancreatica.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pancreatica.org</a></div></li><li class="half_rhythm"><div><b>Pancreatic Cancer Action Network</b></div><div>2221 Rosecrans Avenue</div><div>Suite 7000</div><div>El Segundo CA 90245</div><div><b>Phone:</b> 877-272-6226 (toll-free); 310-725-0025</div><div><b>Fax:</b> 310-725-0029</div><div><b>Email:</b> info@pancan.org</div><div><a href="http://www.pancan.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pancan.org</a></div></li><li class="half_rhythm"><div><b>European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer</b></div><div>NIHR Pancreas Biomedical Research Unit, Royal Liverpool University Hospital</div><div>5th Floor UCD Building</div><div>Daulby Street</div><div>Liverpool L69 3GA</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 151 706 4168</div><div><b>Fax:</b> +44 (0) 151 706 5826</div><div><b>Email:</b> europac@liverpool.ac.uk</div><div><a href="https://www.lctu.org.uk/LCTU_NET/Frontend/?Data=W1tiRzlqWVd4bF1dW09RPT1d" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer</a></div></li></ul></div><div id="pancreatitis-ov.Management"><h2 id="_pancreatitis-ov_Management_">Management</h2><div id="pancreatitis-ov.Evaluations_Following_In"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with hereditary pancreatitis, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Evaluation of pancreatic exocrine function (see <a href="#pancreatitis-ov.Chronic_Pancreatitis">Chronic Pancreatitis</a>, <b>Maldigestion</b>)</div></li><li class="half_rhythm"><div>Evaluation of pancreatic endocrine function (i.e., assessment of glucose tolerance)</div></li><li class="half_rhythm"><div>Consideration of pancreatic cancer surveillance in persons with chronic pancreatitis</div></li></ul></div><div id="pancreatitis-ov.Treatment_of_Manifestati"><h3>Treatment of Manifestations</h3><p>Medical treatment and management for hereditary pancreatitis are similar to those for non-hereditary pancreatitis.</p><div id="pancreatitis-ov.Acute_Pancreatitis"><h4>Acute Pancreatitis</h4><p>Treatment of acute pancreatitis usually focuses on pain management and discontinuation of smoking and alcohol use to slow the rate of progression and to decrease the likelihood of complications, including pancreatic cancer.</p><p>Pancreatic pain can result from pancreatic duct obstruction, parenchyma hypertension, pancreatic ischemia, inflammation, neuropathy, and central pain [<a class="bk_pop" href="#pancreatitis-ov.REF.fasanella.2007.335">Fasanella et al 2007</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.mullady.2011.77">Mullady et al 2011</a>]. Genetic factors, many of which remain unknown or not convincingly accountable, are thought to play a role in pain perception, tolerance, and response to medication.</p><ul><li class="half_rhythm"><div>Analgesics are offered when pancreatic enzyme replacement therapy is not sufficient to control pain.</div></li><li class="half_rhythm"><div>Antioxidants have been reported to improve pain control in a few individuals with hereditary pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.perrault.1994.743">Perrault 1994</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.uomo.2001.58">Uomo et al 2001</a>] and non-alcoholic chronic pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.bhardwaj.2009.149">Bhardwaj et al 2009</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.burton.2011.149">Burton et al 2011</a>].</div></li><li class="half_rhythm"><div>Endoscopic or surgical interventions may be useful for treating obstructive pain [<a class="bk_pop" href="#pancreatitis-ov.REF.clarke.2012.795">Clarke et al 2012</a>].</div></li><li class="half_rhythm"><div>Total pancreatectomy with islet autotransplantation is sometimes considered in patients with severe pain and/or inflammation that cannot be controlled by other approaches [<a class="bk_pop" href="#pancreatitis-ov.REF.bellin.2011.793">Bellin et al 2011</a>].</div></li></ul><p>Endoscopic and surgical interventions are also useful for complications such as pseudocysts, bile-duct or duodenal obstruction, infected pancreatic necrosis, and malignancy.</p><p>Obstructions or calcifications in the pancreatic ducts may be relieved by procedures such as endoscopic retrograde cholangiopancreatography (ERCP), in which endoscopic cannulation of the common bile duct and pancreatic duct is followed by injection of radiographic dye. Decompressing/clearing of blockage decreases pain as well as the number of hospitalizations required and recurrent attacks in many persons with HP [<a class="bk_pop" href="#pancreatitis-ov.REF.dever.2010.46">Dever et al 2010</a>]. Of note, patients with obstruction of a shorter duration have better outcomes than patients in whom treatment is delayed [<a class="bk_pop" href="#pancreatitis-ov.REF.clarke.2012.795">Clarke et al 2012</a>]. Note: Because of the risk for acute pancreatitis following ERCP, it is only recommended for obtaining brushings (for evaluation of strictures) and for therapeutic intervention, not for diagnosis.</p><p>Although a variety of surgical approaches are used for non-cancerous pancreatic disorders that cause pain or obstruction from multiple strictures, pancreatic surgery in those with hereditary pancreatitis is unlikely to stop the underlying inflammatory process. Furthermore, pancreatic surgery often reduces the number of islet cells which are essential in pancreatic endocrine function [<a class="bk_pop" href="#pancreatitis-ov.REF.sutton.2010">Sutton et al 2010</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.kobayashi.2011.193">Kobayashi et al 2011</a>]. Because total pancreatectomy with islet cell auto-transplantation (TPIAT) may be a future option for persons with HP, retaining as many islet cells as possible is an important consideration before proceeding with any pancreatic surgery [<a class="bk_pop" href="#pancreatitis-ov.REF.sutton.2010">Sutton et al 2010</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.bellin.2011.793">Bellin et al 2011</a>].</p><p><b>Pancreatectomy.</b> Although controversial, pancreatectomy has been performed as a last resort to improve the quality of life in those with uncontrolled pain, particularly young adults and children [<a class="bk_pop" href="#pancreatitis-ov.REF.sutton.2010">Sutton et al 2010</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.bellin.2014.27">Bellin et al 2014</a>]. It is recommended that persons in whom pancreatectomy is being considered be referred to specialized centers. In persons with adequate endocrine pancreatic function, islet cell isolation and autotransplantation may be considered at the time of total pancreatectomy [<a class="bk_pop" href="#pancreatitis-ov.REF.bellin.2008.37">Bellin et al 2008</a>]. Note: Caution is needed for islet autotransplantation in older adults with longstanding chronic pancreatitis and diabetes mellitus because the number of islet cells is limited and because of the potential for transplanting malignant cells.</p><p>Total pancreatectomy with islet auto-transplantation (TPIAT) is increasingly used to manage severe manifestations of pancreatitis; however, in most cases pancreatitis can be managed without TPIAT. Thus, TPIAT should only be used as a last resort [<a class="bk_pop" href="#pancreatitis-ov.REF.bellin.2014.27">Bellin et al 2014</a>].</p><p>Issues to consider prior to referral for TPIAT:</p><ul><li class="half_rhythm"><div>The operation is irreversible.</div></li><li class="half_rhythm"><div>Serious and life-threatening complications are associated with the operation (as with other major surgeries).</div></li><li class="half_rhythm"><div>Pain relief is not universal.</div></li><li class="half_rhythm"><div>Protection from diabetes mellitus is often incomplete and of variable duration.</div></li><li class="half_rhythm"><div>Life-long, full-dose pancreatic digestive enzyme replacement therapy will be necessary.</div></li></ul></div><div id="pancreatitis-ov.Chronic_Pancreatitis"><h4>Chronic Pancreatitis</h4><p>Treatment of chronic pancreatitis focuses on improving quality of life by managing pancreatic pain, maldigestion, and diabetes mellitus.</p><p><b>Pain</b> is a variable complication of recurrent and chronic inflammation and ranges from minimal to severe and disabling. Pain can result from inflammation, ischemia, obstructed pancreatic ducts, pseudocysts, and/or maldigestion [<a class="bk_pop" href="#pancreatitis-ov.REF.fasanella.2007.335">Fasanella et al 2007</a>].</p><ul><li class="half_rhythm"><div>One small study from Italy suggested that vitamins and antioxidants reduced pain in hereditary pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.uomo.2001.58">Uomo et al 2001</a>]; two larger studies found that antioxidants helped relieve pain in <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.bhardwaj.2009.149">Bhardwaj et al 2009</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.burton.2011.149">Burton et al 2011</a>].</div></li><li class="half_rhythm"><div>Pain from maldigestion can be improved with pancreatic digestive enzymes [<a class="bk_pop" href="#pancreatitis-ov.REF.dhanasekaran.2010.855">Dhanasekaran &#x00026; Toskes 2010</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.whitcomb.2010.2276">Whitcomb et al 2010</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.burton.2011.149">Burton et al 2011</a>].</div></li><li class="half_rhythm"><div>If the main pancreatic duct is obstructed, a trial of endoscopic treatment is often used for diagnostic, therapeutic, and prognostic reasons in determining longer-term therapy.</div></li><li class="half_rhythm"><div>Surgery has been reported to be helpful by many patients; however, surgical approaches should be postponed if islet autotransplantation is being considered.</div></li><li class="half_rhythm"><div>Pancreatic islet autotransplantation, available in several major centers expert in the treatment of pancreatitis, is used in an attempt to both control severe pain and delay the development of diabetes mellitus [<a class="bk_pop" href="#pancreatitis-ov.REF.sutton.2010">Sutton et al 2010</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.kobayashi.2011.193">Kobayashi et al 2011</a>]. It is recommended that physicians and patients work closely with expert centers since pancreatic islet autotransplantation is irreversible.</div></li></ul><p><b>Maldigestion</b> results from pancreatic exocrine insufficiency, which is the failure of the pancreas to produce enough digestive enzymes to digest a meal.</p><p>Clinical measures of pancreatic exocrine insufficiency include observation of steatorrhea (fat and oil in the stool), symptoms of maldigestion (bloating, gas, cramps, and diarrhea), and nutritional deficiencies (e.g., fat-soluble vitamin deficiency and protein malnutrition with low albumin, prealbumin, or retinal binding protein).</p><p>Pancreatic enzyme deficiency can be identified using invasive or noninvasive testing (see review by <a class="bk_pop" href="#pancreatitis-ov.REF.lieb.2008.3149">Lieb &#x00026; Draganov [2008]</a>). The first two are most commonly used by expert centers in the United States:</p><ul><li class="half_rhythm"><div>Fecal elastase-1 analysis (ScheBo<sup>&#x000ae;</sup> Biotech AG; Giessen, Germany) is a simple and relatively inexpensive test that evaluates the amount of human elastase-1 present in the stool. It can be falsely positive with diarrhea, but can be used while an individual is taking pancreatic enzyme replacement therapy. The test is insensitive for mild pancreatic exocrine insufficiency [<a class="bk_pop" href="#pancreatitis-ov.REF.amann.1996.226">Amann et al 1996</a>].</div></li><li class="half_rhythm"><div>Secretin-stimulated pancreatic bicarbonate secretion testing (ChiRhoStim<sup>&#x000ae;</sup>, ChiRhoClin, Inc; Burtonsville, MD) requires intubation of the duodenum and careful measurement of pancreatic bicarbonate secretion over about an hour (depending on the method). It is considered very sensitive, but only assesses pancreatic duct function.</div></li><li class="half_rhythm"><div>Cholecystokinin (CCK) and its analogs (e.g., CCK-8) or receptor agonists (e.g., cerulean) have also been used to assess acinar cell function.</div></li><li class="half_rhythm"><div>13C-mixed triglyceride breath test is of limited availability in the US. This test measures the ability of pancreatic lipase to digest a special substrate in the intestine after a test meal [<a class="bk_pop" href="#pancreatitis-ov.REF.dom_nguezmu_oz.2007.484">Dom&#x000ed;nguez-Mu&#x000f1;oz et al 2007</a>].</div></li><li class="half_rhythm"><div>72-hour fecal fat is used to demonstrate that pancreatic digestive enzyme supplements are effective in digesting fat in the intestine of persons with severe pancreatic exocrine insufficiency. It is usually performed in a clinical research unit over four to five days during which time the patient eats a special high-fat meal (&#x0003e;100 grams of fat per day) and all stool samples are collected and analyzed. It is not used for diagnosis because of the complexity and inconvenience of the test.</div></li><li class="half_rhythm"><div>Sudan stain, which identifies fat in the stool, is not sensitive or specific for pancreatic insufficiency since undigested oils or fats can be present as a result of:</div><ul><li class="half_rhythm"><div>Their nature (e.g., mineral oil, olestra), or</div></li><li class="half_rhythm"><div>Blocking of pancreatic lipase (e.g., orlistat), or</div></li><li class="half_rhythm"><div>Diseases of the intestinal mucosa.</div></li></ul></li><li class="half_rhythm"><div>Diffusion-weighted MRI. Various "functional" tests have been advocated using abdominal imaging techniques, including secretin-stimulated MRI. Although diffusion-weighted MRI is probably better at detecting the structural changes of chronic pancreatitis than standard MRI [<a class="bk_pop" href="#pancreatitis-ov.REF.akisik.2009.103">Akisik et al 2009</a>], it does not measure function, and fluid volume cannot measure bicarbonate output.</div></li></ul><p>Pancreatic enzyme replacement therapy improves digestion in those with pancreatic insufficiency who have pain with eating, steatorrhea (fat in the stool), and/or diarrhea [<a class="bk_pop" href="#pancreatitis-ov.REF.perrault.1994.743">Perrault 1994</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.whitcomb.2010.2276">Whitcomb et al 2010</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.burton.2011.149">Burton et al 2011</a>]. Pancreatic enzymes most effectively relieve symptoms in persons with steatorrhea and in a subset of persons without steatorrhea [<a class="bk_pop" href="#pancreatitis-ov.REF.bhardwaj.2009.149">Bhardwaj et al 2009</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.burton.2011.149">Burton et al 2011</a>].</p><p>The amount of pancreatic enzyme replacement necessary depends on the diet and on the amount of residual pancreatic function (which diminishes over time). The normal amount of lipase secreted is about 750,000-1,000,000 units (USP) per meal. (Note that earlier papers used IU, and 1 IU = 3 USP units [<a class="bk_pop" href="#pancreatitis-ov.REF.pongprasobchai.2005">Pongprasobchai &#x00026; DiMagno 2005</a>].) Since a minimum of 10% of normal pancreatic enzyme output is needed to digest a meal, about 70,000-80,000 USP units of lipase are required for an average-sized adult (70 kg) with total pancreatic insufficiency. The amount can be reduced for smaller persons and those with residual pancreatic exocrine function &#x02013; while monitoring symptoms and nutritional parameters.</p><p><b>Diabetes mellitus</b> is a common disorder and both type 1 and type 2 can occur in patients with pancreatitis by random chance.</p><p>Type 3c diabetes mellitus is caused by loss of pancreatic tissue as a result of surgery, chronic pancreatitis, or other rare pancreatic diseases [<a class="bk_pop" href="#pancreatitis-ov.REF.rossi.2004.461">Rossi et al 2004</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.cui.2011.279">Cui &#x00026; Andersen 2011</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.andersen.2013.1227">Andersen et al 2013</a>]. Type 3c diabetes mellitus is important because loss of both the insulin-producing beta cells and the glucagon-producing alpha cells results in loss of counter-regulatory hormones and risk for hypoglycemia. Furthermore, it appears to be associated with increased risk for pancreatic cancer, and use of some anti-diabetic agents (e.g., the incretins) may be of concern [<a class="bk_pop" href="#pancreatitis-ov.REF.andersen.2013.1227">Andersen et al 2013</a>].</p><p>Chronic pancreatitis is associated with a gradual loss of islet cell function. The following may be of benefit [<a class="bk_pop" href="#pancreatitis-ov.REF.cui.2011.279">Cui &#x00026; Andersen 2011</a>].</p><ul><li class="half_rhythm"><div>Monitoring for glucose intolerance</div></li><li class="half_rhythm"><div>Optimizing pancreatic insulin secretion with pancreatic enzyme replacement therapy via amino acid and fatty acid-stimulated release of endogenous incretins from the foregut, with the addition of anti-diabetic agents as needed</div></li><li class="half_rhythm"><div>Synchronizing the entry of nutrients into the circulation with exogenous insulin therapy delivery through diet and promoting predictable early nutrient digestion and absorption with pancreatic enzyme replacement therapy</div></li><li class="half_rhythm"><div>Use of metformin as an oral anti-diabetic agent [<a class="bk_pop" href="#pancreatitis-ov.REF.decensi.2010.1451">Decensi et al 2010</a>]</div></li><li class="half_rhythm"><div>Routine screening of patients with chronic pancreatitis for glucose intolerance; recommendations for management and referral have recently been published [<a class="bk_pop" href="#pancreatitis-ov.REF.rickels.2013b.2890">Rickels et al 2013b</a>].</div></li></ul><p>See also <a class="bk_pop" href="#pancreatitis-ov.REF.rickels.2013a.336">Rickels et al [2013a]</a> for new consensus guidelines on management of diabetes in pancreatitis.</p></div></div><div id="pancreatitis-ov.Prevention_of_Primary_Ma"><h3>Prevention of Primary Manifestations</h3><p>The ability to prevent the primary manifestations of hereditary pancreatitis (regardless of genetic cause) is limited.</p><p>The following recommendations are for individuals with (or at risk for) hereditary pancreatitis; beginning in early childhood can help prevent attacks of acute pancreatitis:</p><ul><li class="half_rhythm"><div><b>Low-fat diet.</b> No formal guidelines for amount of dietary fat exist; however, some physicians recommend a low-fat diet to minimize pancreatic stimulation. If a low-fat diet is chosen, extra attention to providing fat soluble vitamins (A, D, E, K) is needed.</div></li><li class="half_rhythm"><div><b>Multiple small meals.</b> No evidence-based guidelines exist; however, small meals may minimize pancreatic exocrine stimulation.</div></li><li class="half_rhythm"><div><b>Good hydration.</b> Poor hydration (for example during exercise) can lead to episodes of pancreatitis [Authors, unpublished].</div></li><li class="half_rhythm"><div><b>Antioxidants.</b> One small study suggested that antioxidants may be useful in reducing the likelihood of acute pancreatitis in persons at risk for hereditary pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.uomo.2001.58">Uomo et al 2001</a>]. Anti-oxidant therapy is very low risk and low cost, and thus, an appropriate first course of action [<a class="bk_pop" href="#pancreatitis-ov.REF.bhardwaj.2009.149">Bhardwaj et al 2009</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.burton.2011.149">Burton et al 2011</a>].</div></li><li class="half_rhythm"><div><b>Cessation/abstinence from smoking and alcohol</b>, the strongest recommendation for all persons with pancreatitis. Substantial evidence shows that oxidative stress from alcohol and tobacco smoke is inherently linked to progression and pain in pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.schoenberg.1995.1306s">Schoenberg et al 1995</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.petrov.2010.562">Petrov 2010</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.tandon.2011.2757">Tandon &#x00026; Garg 2011</a>]. This observation provides a pathophysiologic link for alcohol and tobacco smoking as risk factors, and also suggests that nutrition control may be an important preventive measure. Smoking is also a major risk for pancreatic cancer [<a class="bk_pop" href="#pancreatitis-ov.REF.lowenfels.2001.169">Lowenfels et al 2001</a>]. Note: Men with one high-risk <i>CLDN2</i> variant and women with two high-risk <i>CLDN2</i> variants should be strongly urged to stop drinking immediately and directed to effective treatment programs.</div></li></ul></div><div id="pancreatitis-ov.Circumstances_to_Avoid"><h3>Circumstances to Avoid</h3><p><b>Alcohol and tobacco use</b> exacerbate all pancreatitis regardless of cause [<a class="bk_pop" href="#pancreatitis-ov.REF.lowenfels.1997.444">Lowenfels &#x00026; Whitcomb 1997</a>]. In combination, smoking and alcohol use increases the risk of developing pancreatitis eightfold [<a class="bk_pop" href="#pancreatitis-ov.REF.yadav.2009.1035">Yadav et al 2009</a>]. Smoking doubles the risk for all forms of pancreatitis, including hereditary pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.maisonneuve.2005.510">Maisonneuve et al 2005</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.yadav.2009.1035">Yadav et al 2009</a>]. Tobacco use is also linked with early onset of pancreatic cancer [<a class="bk_pop" href="#pancreatitis-ov.REF.lowenfels.2001.169">Lowenfels et al 2001</a>].</p><p><b>Dehydration</b> worsens episodes of acute pancreatitis. Maintaining good hydration may be helpful in minimizing attacks, especially since nausea, vomiting, and loss of appetite limit oral intake during an attack.</p><p><b>Physical and emotional stresses</b> aggravate pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.applebaum.2000.575">Applebaum et al 2000</a>]. Avoiding these stressors in families with HP may prevent or delay worsening of symptoms and progression of disease. Yoga and other relaxation techniques may increase quality of life in persons with pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.sareen.2007.391">Sareen et al 2007</a>]. Some patients report that regular exercise, such as running, helps reduce the frequency of episodes of pancreatitis [Authors, unpublished].</p></div><div id="pancreatitis-ov.Surveillance"><h3>Surveillance</h3><p>Surveillance for pancreatic cancer in high-risk groups with pancreatitis has been considered (see <a href="#pancreatitis-ov.Definitions">Definitions</a>, <b>Chronic pancreatitis</b> for discussion of pancreatic cancer risk). However, because long-standing chronic pancreatitis results in pancreatic scarring and fibrosis that make assessment of abnormalities difficult [<a class="bk_pop" href="#pancreatitis-ov.REF.ulrich.2001.416">Ulrich 2001</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.brand.2007.1460">Brand et al 2007</a>], it is recommended that concerned individuals be referred to a surveillance program that includes biomarker research and other new techniques.</p></div><div id="pancreatitis-ov.Evaluation_of_Relatives"><h3>Evaluation of Relatives at Risk</h3><p>It is recommended that relatives at risk for <i>PRSS1</i>-related hereditary pancreatitis be offered <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the family-specific <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>PRSS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (see Establishing the Diagnosis, <a href="#pancreatitis-ov.Molecular_Genetic_Testin">Molecular Genetic Testing</a>) to allow early diagnosis and prevention and/or management of symptoms [<a class="bk_pop" href="#pancreatitis-ov.REF.applebaum.2000.575">Applebaum et al 2000</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.ellis.2001.405">Ellis et al 2001</a>, <a class="bk_pop" href="#pancreatitis-ov.REF.fink.2007.325">Fink et al 2007</a>]. Testing of children is appropriate in families with early onset symptoms. Presymptomatic testing is best performed in the context of <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> [<a class="bk_pop" href="#pancreatitis-ov.REF.fink.2007.325">Fink et al 2007</a>].</p><p>See <a href="#pancreatitis-ov.Related_Genetic_Counseli">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="pancreatitis-ov.Therapies_Under_Investig"><h3>Therapies Under Investigation</h3><p>Currently, chemopreventive agents such as calcium-channel blockers are being investigated for treatment of manifestations of hereditary pancreatitis [<a class="bk_pop" href="#pancreatitis-ov.REF.morinville.2007.308">Morinville et al 2007</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="pancreatitis-ov.References"><h2 id="_pancreatitis-ov_References_">References</h2><div id="pancreatitis-ov.Published_Guidelines__Co"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.bellin.2014.27">Bellin MD, Freeman ML, Gelrud A, Slivka A, Clavel A, Humar A, Schwarzenberg SJ, Lowe ME, Rickels MR, Whitcomb DC, Matthews JB. Total pancreatectomy and islet autotransplantation in chronic pancreatitis: Recommendations from PancreasFest. <span><span class="ref-journal">Pancreatology. </span>2014;<span class="ref-vol">14</span>:27–35.</span> [<a href="/pmc/articles/PMC4058640/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4058640</span></a>] [<a href="/pubmed/24555976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24555976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.ellis.2001.405">Ellis I, Lerch MM, Whitcomb DC. Consensus Committees of the European Registry of Hereditary Pancreatic Diseases, Midwest Multi-Center Pancreatic Study Group, International Association of Pancreatology &#x02013; Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. <span><span class="ref-journal">Pancreatology. </span>2001;<span class="ref-vol">1</span>:405–15.</span> [<a href="/pubmed/12120217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12120217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.rickels.2013.336">Rickels MR, Bellin M, Toledo FG, Robertson RP, Andersen DK, Chari ST, Brand R, Frulloni L, Anderson MA, Whitcomb DC. PancreasFest Recommendation Conference Participants. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest. <span><span class="ref-journal">Pancreatology. </span>2013;<span class="ref-vol">13</span>:336–42.</span> [<a href="/pmc/articles/PMC3830751/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3830751</span></a>] [<a href="/pubmed/23890130" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23890130</span></a>]</div></li></ul></div><div id="pancreatitis-ov.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.akisik.2009.103">Akisik MF, Aisen AM, Sandrasegaran K, Jennings SG, Lin C, Sherman S, Lin JA, Rydberg M. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. <span><span class="ref-journal">Radiology. </span>2009;<span class="ref-vol">250</span>:103–9.</span> [<a href="/pubmed/19001148" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19001148</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.amann.1996.226">Amann ST, Bishop M, Curington C, Toskes PP. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis. <span><span class="ref-journal">Pancreas. </span>1996;<span class="ref-vol">13</span>:226–30.</span> [<a href="/pubmed/8884841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8884841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.andersen.2013.1227">Andersen DK, Andren-Sandberg &#x000c5;, Duell EJ, Goggins M, Korc M, Petersen GM, Smith JP, Whitcomb DC. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. <span><span class="ref-journal">Pancreas. </span>2013;<span class="ref-vol">42</span>:1227–37.</span> [<a href="/pmc/articles/PMC3878448/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3878448</span></a>] [<a href="/pubmed/24152948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24152948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.applebaum.2000.575">Applebaum SE, Kant JA, Whitcomb DC, Ellis IH. Genetic testing: counseling, laboratory and regulatory issues and the EUROPAC protocol for ethical research in multi-center studies of inherited pancreatic diseases. <span><span class="ref-journal">Med Clin North Am. </span>2000;<span class="ref-vol">84</span>:575–88.</span> [<a href="/pubmed/10872415" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10872415</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.banks.2013.102">Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS, et al.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. <span><span class="ref-journal">Gut. </span>2013;<span class="ref-vol">62</span>:102–11.</span> [<a href="/pubmed/23100216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23100216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.banks.2006.2379">Banks PA, Freeman ML, et al.  Practice guidelines in acute pancreatitis. <span><span class="ref-journal">Am J Gastroenterol. </span>2006;<span class="ref-vol">101</span>:2379–400.</span> [<a href="/pubmed/17032204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17032204</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.becher.1999.577">Becher MW, Wills ML, Noll WW, Hurko O, Price DL. Kearns-Sayre syndrome with features of Pearson&#x02019;s marrow-pancreas syndrome and a novel 2905-base pair mitochondrial DNA deletion. <span><span class="ref-journal">Hum Pathol. </span>1999;<span class="ref-vol">30</span>:577–81.</span> [<a href="/pubmed/10333230" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10333230</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.beer.2013.1616">Beer S, Zhou J, Szab&#x000f3; A, Keiles S, Chandak GR, Witt H, Sahin-T&#x000f3;th M. Comprehensive functional analysis of chymotrypsin C (CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk. <span><span class="ref-journal">Gut. </span>2013;<span class="ref-vol">62</span>:1616–24.</span> [<a href="/pmc/articles/PMC3660471/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3660471</span></a>] [<a href="/pubmed/22942235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22942235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.bellin.2008.37">Bellin MD, Carlson AM, Kobayashi T, Gruessner AC, Hering BJ, Moran A, Sutherland DE. Outcome after pancreatectomy and islet autotransplantation in a pediatric population. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2008;<span class="ref-vol">47</span>:37–44.</span> [<a href="/pubmed/18607267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18607267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.bellin.2014.27_1">Bellin MD, Freeman ML, Gelrud A, Slivka A, Clavel A, Humar A, Schwarzenberg SJ, Lowe ME, Rickels MR, Whitcomb DC, Matthews JB. Total pancreatectomy and islet autotransplantation in chronic pancreatitis: Recommendations from PancreasFest. <span><span class="ref-journal">Pancreatology. </span>2014;<span class="ref-vol">14</span>:27–35.</span> [<a href="/pmc/articles/PMC4058640/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4058640</span></a>] [<a href="/pubmed/24555976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24555976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.bellin.2011.793">Bellin MD, Freeman ML, Schwarzenberg SJ, Dunn TB, Beilman GJ, Vickers SM, Chinnakotla S, Balamurugan AN, Hering BJ, Radosevich DM, Moran A, Sutherland DE. Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2011;<span class="ref-vol">9</span>:793–9.</span> [<a href="/pmc/articles/PMC3163759/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3163759</span></a>] [<a href="/pubmed/21683160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21683160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.bhardwaj.2009.149">Bhardwaj P, Garg PK, Maulik SK, Saraya A, Tandon RK, Acharya SK. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. <span><span class="ref-journal">Gastroenterology. </span>2009;<span class="ref-vol">136</span>:149–59.e2.</span> [<a href="/pubmed/18952082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18952082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.boocock.2003.97">Boocock GR, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR, Rommens JM. Mutations in SBDS are associated with Shwachman-Diamond syndrome. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:97–101.</span> [<a href="/pubmed/12496757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12496757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.brand.2007.1460">Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI, et al.  Advances in counselling and surveillance of patients at risk for pancreatic cancer. <span><span class="ref-journal">Gut. </span>2007;<span class="ref-vol">56</span>:1460–9.</span> [<a href="/pmc/articles/PMC2000231/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2000231</span></a>] [<a href="/pubmed/17872573" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17872573</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.burton.2011.149">Burton F, Alkaade S, Collins D, Muddana V, Slivka A, Brand RE, Gelrud A, Banks PA, Sherman S, Anderson MA, Romagnuolo J, Lawrence C, Baillie J, Gardner TB, Lewis MD, Amann ST, Lieb JG 2nd, O&#x02019;Connell M, Kennard ED, Yadav D, Whitcomb DC, Forsmark CE, et al.  Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States. <span><span class="ref-journal">Aliment Pharmacol Ther. </span>2011;<span class="ref-vol">33</span>:149–59.</span> [<a href="/pmc/articles/PMC3142582/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3142582</span></a>] [<a href="/pubmed/21083584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21083584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.chang.2009.287">Chang MC, Chang YT, Wei SC, Liang PC, Jan IS, Su YN, Kuo CH, Wong JM. Association of novel chymotrypsin C gene variations and haplotypes in patients with chronic pancreatitis in Chinese in Taiwan. <span><span class="ref-journal">Pancreatology. </span>2009;<span class="ref-vol">9</span>:287–92.</span> [<a href="/pubmed/19407484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19407484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.chen.2000.463">Chen JM, Ferec C. Gene conversion-like missense mutations in the human cationic trypsinogen gene and insights into the molecular evolution of the human trypsinogen family. <span><span class="ref-journal">Mol Genet Metab. </span>2000;<span class="ref-vol">71</span>:463–9.</span> [<a href="/pubmed/11073713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11073713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.chen.2008.102">Chen JM, Masson E, Le Mar&#x000e9;chal C, F&#x000e9;rec C. Copy number variations in chronic pancreatitis. <span><span class="ref-journal">Cytogenet Genome Res. </span>2008;<span class="ref-vol">123</span>:102–7.</span> [<a href="/pubmed/19287144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19287144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.clarke.2012.795">Clarke B, Slivka A, Tomizawa Y, Sanders M, Papachristou GI, Whitcomb DC, Yadav D. Endoscopic therapy is effective for patients with chronic pancreatitis. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2012;<span class="ref-vol">10</span>:795–802.</span> [<a href="/pmc/articles/PMC3381994/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3381994</span></a>] [<a href="/pubmed/22245964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22245964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.cui.2011.279">Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. <span><span class="ref-journal">Pancreatology. </span>2011;<span class="ref-vol">11</span>:279–94.</span> [<a href="/pubmed/21757968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21757968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.decensi.2010.1451">Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. <span><span class="ref-journal">Cancer Prev Res (Phila). </span>2010;<span class="ref-vol">3</span>:1451–61.</span> [<a href="/pubmed/20947488" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20947488</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.dever.2010.46">Dever JB, Irani S, Brandabur J, Traverso LW, Kozarek R. Outcomes of interventional ERCP in hereditary pancreatitis. <span><span class="ref-journal">J Clin Gastroenterol. </span>2010;<span class="ref-vol">44</span>:46–51.</span> [<a href="/pubmed/19713862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19713862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.dhanasekaran.2010.855">Dhanasekaran R, Toskes PP. Pancrelipase for pancreatic disorders: An update. <span><span class="ref-journal">Drugs Today (Barc). </span>2010;<span class="ref-vol">46</span>:855–66.</span> [<a href="/pubmed/21225024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21225024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.dom_nguezmu_oz.2007.484">Dom&#x000ed;nguez-Mu&#x000f1;oz JE, Iglesias-Garc&#x000ed;a J, Vilari&#x000f1;o-Insua M, Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2007;<span class="ref-vol">5</span>:484–8.</span> [<a href="/pubmed/17445754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17445754</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.durie.1996.169">Durie PR. Inherited and congenital disorders of the exocrine pancreas. <span><span class="ref-journal">Gastroenterologist. </span>1996;<span class="ref-vol">4</span>:169–87.</span> [<a href="/pubmed/8891682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8891682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.ellis.2004.839">Ellis I. Genetic counseling for hereditary pancreatitis--the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1. <span><span class="ref-journal">Gastroenterol Clin North Am. </span>2004;<span class="ref-vol">33</span>:839–54.</span> [<a href="/pubmed/15528021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15528021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.ellis.2001.405_1">Ellis I, Lerch MM, Whitcomb DC, et al.  Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. <span><span class="ref-journal">Pancreatology. </span>2001;<span class="ref-vol">1</span>:405–15.</span> [<a href="/pubmed/12120217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12120217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.etemad.2001.682">Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. <span><span class="ref-journal">Gastroenterology. </span>2001;<span class="ref-vol">120</span>:682–707.</span> [<a href="/pubmed/11179244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11179244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.fasanella.2007.335">Fasanella KE, Davis B, Lyons J, Chen Z, Lee KK, Slivka A, Whitcomb DC. Pain in chronic pancreatitis and pancreatic cancer. <span><span class="ref-journal">Gastroenterol Clin North Am. </span>2007;<span class="ref-vol">36</span>:335–64.</span> [<a href="/pubmed/17533083" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17533083</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.fink.2007.325">Fink EN, Kant JA, Whitcomb DC. Genetic counseling for nonsyndromic pancreatitis. <span><span class="ref-journal">Gastroenterol Clin North Am. </span>2007;<span class="ref-vol">36</span>:325–33.</span> [<a href="/pubmed/17533082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17533082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.hopewell.1990.760">Hopewell JW, Barnes DW, Robbins ME, Corp M, Sansom JM, Young CM, Wiernik G. The relative biological effectiveness of fractionated doses of fast neutrons (42 MeVd----Be) for normal tissues in the pig. II. Late effects on cutaneous and subcutaneous tissues. <span><span class="ref-journal">Br J Radiol. </span>1990;<span class="ref-vol">63</span>:760–70.</span> [<a href="/pubmed/2242473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2242473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.khurana.2001.102">Khurana V, Barkin JS. Pancreatitis induced by environmental toxins. <span><span class="ref-journal">Pancreas. </span>2001;<span class="ref-vol">22</span>:102–5.</span> [<a href="/pubmed/11138962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11138962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.kobayashi.2011.193">Kobayashi T, Manivel JC, Carlson AM, Bellin MD, Moran A, Freeman ML, Bielman GJ, Hering BJ, Dunn T, Sutherland DE. Correlation of histopathology, islet yield, and islet graft function after islet autotransplantation in chronic pancreatitis. <span><span class="ref-journal">Pancreas. </span>2011;<span class="ref-vol">40</span>:193–9.</span> [<a href="/pubmed/21404456" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21404456</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.larusch.2011.467">LaRusch J, Whitcomb DC. Genetics of pancreatitis. <span><span class="ref-journal">Curr Opin Gastroenterol. </span>2011;<span class="ref-vol">27</span>:467–74.</span> [<a href="/pmc/articles/PMC3704192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3704192</span></a>] [<a href="/pubmed/21844754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21844754</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.larusch.2012.258">LaRusch J, Barmada MM, Solomon S, Whitcomb DC. Whole exome sequencing identifies multiple, complex etiologies in an idiopathic hereditary pancreatitis kindred. <span><span class="ref-journal">JOP. </span>2012;<span class="ref-vol">13</span>:258–62.</span> [<a href="/pmc/articles/PMC3651649/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3651649</span></a>] [<a href="/pubmed/22572128" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22572128</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.lee.2011.478">Lee YJ, Kim KM, Choi JH, Lee BH, Kim GH, Yoo HW. High incidence of PRSS1 and SPINK1 mutations in Korean children with acute recurrent and chronic pancreatitis. <span><span class="ref-journal">J Pediatr Gastroenterol Nutr. </span>2011;<span class="ref-vol">52</span>:478–81.</span> [<a href="/pubmed/21415673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21415673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.lerch.2006.219">Lerch MM, Zenker M, Turi S, Mayerle J. Developmental and metabolic disorders of the pancreas. <span><span class="ref-journal">Endocrinol Metab Clin North Am. </span>2006;<span class="ref-vol">35</span>:219–41.</span> [<a href="/pubmed/16632089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16632089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.lieb.2008.3149">Lieb JG 2nd, Draganov PV. Pancreatic function testing: here to stay for the 21st century. <span><span class="ref-journal">World J Gastroenterol. </span>2008;<span class="ref-vol">14</span>:3149–58.</span> [<a href="/pmc/articles/PMC2712845/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2712845</span></a>] [<a href="/pubmed/18506918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18506918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.lowenfels.1997.444">Lowenfels AB, Whitcomb DC. Estimating the number of hereditary panceatitis (HP) patients in the USA. <span><span class="ref-journal">Pancreas. </span>1997;<span class="ref-vol">15</span>:444.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.lowenfels.2001.169">Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, DiMagno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. <span><span class="ref-journal">JAMA. </span>2001;<span class="ref-vol">286</span>:169–70.</span> [<a href="/pubmed/11448279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11448279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.maisonneuve.2005.510">Maisonneuve P, Lowenfels AB, M&#x000fc;llhaupt B, Cavallini G, Lankisch PG, Andersen JR, Dimagno EP, Andr&#x000e9;n-Sandberg A, Domell&#x000f6;f L, Frulloni L, Ammann RW. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. <span><span class="ref-journal">Gut. </span>2005;<span class="ref-vol">54</span>:510–4.</span> [<a href="/pmc/articles/PMC1774435/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1774435</span></a>] [<a href="/pubmed/15753536" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15753536</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.masson.2008a.83">Masson E, Chen JM, Scotet V, Le Marechal C, Ferec C. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. <span><span class="ref-journal">Hum Genet. </span>2008a;<span class="ref-vol">123</span>:83–91.</span> [<a href="/pubmed/18172691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18172691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.masson.2008b.82">Masson E, Le Mar&#x000e9;chal C, Chandak GR, Lamoril J, Bezieau S, Mahurkar S, Bhaskar S, Reddy DN, Chen JM, F&#x000e9;rec C. Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2008b;<span class="ref-vol">6</span>:82–8.</span> [<a href="/pubmed/18063422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18063422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.masson.2008c.521">Masson E, Le Marechal C, Delcenserie R, Chen JM, Ferec C. Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. <span><span class="ref-journal">Hum Genet. </span>2008c;<span class="ref-vol">123</span>:521–9.</span> [<a href="/pubmed/18461367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18461367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.morinville.2007.308">Morinville VD, Lowe ME, Elinoff BD, Whitcomb DC. Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis. <span><span class="ref-journal">Pancreas. </span>2007;<span class="ref-vol">35</span>:308–12.</span> [<a href="/pubmed/18090235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18090235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.mullady.2011.77">Mullady DK, Yadav D, Amann ST, O&#x02019;Connell MR, Barmada MM, Elta GH, Scheiman JM, Wamsteker EJ, Chey WD, Korneffel ML, Weinman BM, Slivka A, Sherman S, Hawes RH, Brand RE, Burton FR, Lewis MD, Gardner TB, Gelrud A, DiSario J, Baillie J, Banks PA, Whitcomb DC, Anderson MA. NAPS2 Consortium. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. <span><span class="ref-journal">Gut. </span>2011;<span class="ref-vol">60</span>:77–84.</span> [<a href="/pmc/articles/PMC6748627/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6748627</span></a>] [<a href="/pubmed/21148579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21148579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.neoptolemos.2000.1955">Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. <span><span class="ref-journal">Lancet. </span>2000;<span class="ref-vol">355</span>:1955–60.</span> [<a href="/pubmed/10859041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10859041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.nitsche.2012.131">Nitsche C, Maertin S, Scheiber J, Ritter CA, Lerch MM, Mayerle J. Drug-induced pancreatitis. <span><span class="ref-journal">Curr Gastroenterol Rep. </span>2012;<span class="ref-vol">14</span>:131–8.</span> [<a href="/pubmed/22314811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22314811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.o_connor.2011.w2215">O&#x02019;Connor OJ, McWilliams S, Maher MM. Imaging of acute pancreatitis. <span><span class="ref-journal">AJR Am J Roentgenol. </span>2011;<span class="ref-vol">197</span>:W221-5.</span> [<a href="/pubmed/21785045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21785045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.perrault.1994.743">Perrault J. Hereditary pancreatitis. <span><span class="ref-journal">Gastroenterol Clin North Am. </span>1994;<span class="ref-vol">23</span>:743–52.</span> [<a href="/pubmed/7698830" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7698830</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.petrov.2010.562">Petrov MS. Therapeutic implications of oxidative stress in acute and chronic pancreatitis. <span><span class="ref-journal">Curr Opin Clin Nutr Metab Care. </span>2010;<span class="ref-vol">13</span>:562–8.</span> [<a href="/pubmed/20543682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20543682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.pf_tzer.2000.615">Pf&#x000fc;tzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, Furey WF, Whitcomb DC. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. <span><span class="ref-journal">Gastroenterology. </span>2000;<span class="ref-vol">119</span>:615–23.</span> [<a href="/pubmed/10982753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10982753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.pidasheva.2004.107">Pidasheva S, D&#x02019;Souza-Li L, Canaff L, Cole DE, Hendy GN. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">24</span>:107–11.</span> [<a href="/pubmed/15241791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15241791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.pongprasobchai.2005">Pongprasobchai S, DiMagno EP. Treatment of exocrine pancreatic insufficiency. In: Forsmark CE, ed. <em>Pancreatitis and Its Complications</em>. Totowa, NJ: Humana Press. 2005;295-312.</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.raeder.2006.54">Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V, Nermoen I, Eide SA, Grevle L, Bj&#x000f8;rkhaug L, Sagen JV, Aksnes L, S&#x000f8;vik O, Lombardo D, Molven A, Nj&#x000f8;lstad PR. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. <span><span class="ref-journal">Nat Genet. </span>2006;2006;<span class="ref-vol">38</span>:54–62.</span> [<a href="/pubmed/16369531" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16369531</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.rebours.2009.97">Rebours V, Boutron-Ruault MC, Schnee M, F&#x000e9;rec C, Le Mar&#x000e9;chal C, Hentic O, Maire F, Hammel P, Ruszniewski P, L&#x000e9;vy P. The natural history of hereditary pancreatitis: a national series. <span><span class="ref-journal">Gut. </span>2009;<span class="ref-vol">58</span>:97–103.</span> [<a href="/pubmed/18755888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18755888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.rebours.2008.111">Rebours V, Boutron-Ruault MC, Schnee M, F&#x000e9;rec C, Maire F, Hammel P, Ruszniewski P, L&#x000e9;vy P. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. <span><span class="ref-journal">Am J Gastroenterol. </span>2008;<span class="ref-vol">103</span>:111–9.</span> [<a href="/pubmed/18184119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18184119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.rickels.2013a.336">Rickels MR, Bellin M, Toledo FG, Robertson RP, Andersen DK, Chari ST, Brand R, Frulloni L, Anderson MA, Whitcomb DC, et al.  Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. <span><span class="ref-journal">Pancreatology. </span>2013a;<span class="ref-vol">13</span>:336–42.</span> [<a href="/pmc/articles/PMC3830751/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3830751</span></a>] [<a href="/pubmed/23890130" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23890130</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.rickels.2013b.2890">Rickels MR, Liu C, Shlansky-Goldberg RD, Soleimanpour SA, Vivek K, Kamoun M, Min Z, Markmann E, Palangian M, Dalton-Bakes C, Fuller C, Chiou AJ, Barker CF, Luning Prak ET, Naji A. Improvement in &#x003b2;-cell secretory capacity after human islet transplantation according to the CIT07 protocol. <span><span class="ref-journal">Diabetes. </span>2013b;<span class="ref-vol">62</span>:2890–7.</span> [<a href="/pmc/articles/PMC3717864/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3717864</span></a>] [<a href="/pubmed/23630300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23630300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.rosendahl.2013.582">Rosendahl J, Landt O, Bernadova J, Kovacs P, Teich N, B&#x000f6;deker H, Keim V, Ruffert C, M&#x000f6;ssner J, Kage A, Stumvoll M, Groneberg D, Kr&#x000fc;ger R, Luck W, Treiber M, Becker M, Witt H. CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated? <span><span class="ref-journal">Gut. </span>2013;<span class="ref-vol">62</span>:582–92.</span> [<a href="/pubmed/22427236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22427236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.rosendahl.2008.78">Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsv&#x000e1;ri B, Landt O, Schulz HU, Gress TM, Pf&#x000fc;tzer R, L&#x000f6;hr M, Kovacs P, Bl&#x000fc;her M, Stumvoll M, Choudhuri G, Hegyi P, te Morsche RH, Drenth JP, Truninger K, Macek M Jr, Puhl G, Witt U, Schmidt H, B&#x000fc;ning C, Ockenga J, Kage A, Groneberg DA, Nickel R, Berg T, Wiedenmann B, B&#x000f6;deker H, Keim V, M&#x000f6;ssner J, Teich N, Sahin-T&#x000f3;th M, Chymotrypsin C. CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:78–82.</span> [<a href="/pmc/articles/PMC2650829/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2650829</span></a>] [<a href="/pubmed/18059268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18059268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.rossi.2004.461">Rossi L, Parvin S, Hassan Z, Hildebrand P, Keller U, Ali L, Beglinger C, Azad Khan AK, Whitcomb DC, Gyr N. Diabetes mellitus in tropical chronic pancreatitis is not just a secondary type of diabetes. <span><span class="ref-journal">Pancreatology. </span>2004;<span class="ref-vol">4</span>:461–7.</span> [<a href="/pubmed/15258409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15258409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.r_tig.1990.1601">R&#x000f6;tig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, Romero N, Schmitz J, Rustin P, Fischer A, Saudubray JM. Pearson&#x02019;s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. <span><span class="ref-journal">J Clin Invest. </span>1990;<span class="ref-vol">86</span>:1601–8.</span> [<a href="/pmc/articles/PMC296909/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC296909</span></a>] [<a href="/pubmed/2243133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2243133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.sareen.2007.391">Sareen S, Kumari V, Gajebasia KS, Gajebasia NK. Yoga: a tool for improving the quality of life in chronic pancreatitis. <span><span class="ref-journal">World J Gastroenterol. </span>2007;<span class="ref-vol">13</span>:391–7.</span> [<a href="/pmc/articles/PMC4065893/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4065893</span></a>] [<a href="/pubmed/17230607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17230607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.schneider.2011.162">Schneider A, Larusch J, Sun X, Aloe A, Lamb J, Hawes R, Cotton P, Brand RE, Anderson MA, Money ME, Banks PA, Lewis MD, Baillie J, Sherman S, Disario J, Burton FR, Gardner TB, Amann ST, Gelrud A, George R, Rockacy MJ, Kassabian S, Martinson J, Slivka A, Yadav D, Oruc N, Barmada MM, Frizzell R, Whitcomb DC. Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis. <span><span class="ref-journal">Gastroenterology. </span>2011;<span class="ref-vol">140</span>:162–71.</span> [<a href="/pmc/articles/PMC3171690/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3171690</span></a>] [<a href="/pubmed/20977904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20977904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.schoenberg.1995.1306s">Schoenberg MH, Birk D, Beger HG. Oxidative stress in acute and chronic pancreatitis. <span><span class="ref-journal">Am J Clin Nutr. </span>1995;<span class="ref-vol">62</span>:1306S–14S.</span> [<a href="/pubmed/7495225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7495225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.solomon.2012.112">Solomon S, Whitcomb DC. Genetics of pancreatitis: an update for clinicians and genetic counselors. <span><span class="ref-journal">Curr Gastroenterol Rep. </span>2012;2012;<span class="ref-vol">14</span>:112–7.</span> [<a href="/pmc/articles/PMC5654383/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5654383</span></a>] [<a href="/pubmed/22314809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22314809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.sutton.2010">Sutton JM, Schmulewitz N, Sussman JJ, Smith M, Kurland JE, Brunner JE, Salehi M, Choe KA, Ahmad SA. Total pancreatectomy and islet cell autotransplantation as a means of treating patients with Surgery. 2010;148:676-85. [<a href="/pubmed/20846557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20846557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.tandon.2011.2757">Tandon RK, Garg PK. Oxidative stress in chronic pancreatitis: pathophysiological relevance and management. <span><span class="ref-journal">Antioxid Redox Signal. </span>2011;<span class="ref-vol">15</span>:2757–66.</span> [<a href="/pubmed/21902596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21902596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.ulrich.2001.416">Ulrich CD 2nd. Pancreatic cancer in hereditary pancreatitis &#x02013; Consensus guidelines for prevention, screening, and treatment. <span><span class="ref-journal">Pancreatology. </span>2001;<span class="ref-vol">1</span>:416–22.</span> [<a href="/pubmed/12120218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12120218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.uomo.2001.58">Uomo G, Talamini G, Rabitti PG. Antioxidant treatment in hereditary pancreatitis. A pilot study on three young patients. <span><span class="ref-journal">Dig Liver Dis. </span>2001;<span class="ref-vol">33</span>:58–62.</span> [<a href="/pubmed/11303976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11303976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.whitcomb.2012.418">Whitcomb DC. What is personalized medicine and what should it replace? <span><span class="ref-journal">Nat Rev Gastroenterol Hepatol. </span>2012;<span class="ref-vol">9</span>:418–24.</span> [<a href="/pmc/articles/PMC3684057/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3684057</span></a>] [<a href="/pubmed/22614753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22614753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.whitcomb.2012.1349">Whitcomb DC, LaRusch J, Krasinskas AM, Klei L, Smith JP, Brand RE, Neoptolemos JP, Lerch MM, Tector M, Sandhu BS, Guda NM, Orlichenko L, Alkaade S, Amann ST, Anderson MA, Baillie J, Banks PA, Conwell D, Cot&#x000e9; GA, Cotton PB, DiSario J, Farrer LA, Forsmark CE, Johnstone M, Gardner TB, Gelrud A, Greenhalf W, Haines JL, Hartman DJ, Hawes RA, Lawrence C, Lewis M, Mayerle J, Mayeux R, Melhem NM, Money ME, Muniraj T, Papachristou GI, Pericak-Vance MA, Romagnuolo J, Schellenberg GD, Sherman S, Simon P, Singh VP, Slivka A, Stolz D, Sutton R, Weiss FU, Wilcox CM, Zarnescu NO, Wisniewski SR, O&#x02019;Connell MR, Kienholz ML, Roeder K, Barmada MM, Yadav D, Devlin B, et al.  Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1349–54.</span> [<a href="/pmc/articles/PMC3510344/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3510344</span></a>] [<a href="/pubmed/23143602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23143602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.whitcomb.2010.2276">Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. <span><span class="ref-journal">Am J Gastroenterol. </span>2010;<span class="ref-vol">105</span>:2276–86.</span> [<a href="/pubmed/20502447" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20502447</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.whitcomb.2010">Whitcomb DC, Lowe ME. Hereditary, familial and genetic disorders of the pancreas and pancreatic disorders in childhood. In: Feldman M, Friedman LS, Sleisenger MH, eds. <em>Sleisenger and Fordtran&#x02019;s Gastrointestinal and Liver Disease.</em> 9 ed. Philadelphia, PA: WB Saunders Company; 2010:931-57.</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.whitcomb.1999.253">Whitcomb DC, Ulrich CD 2nd. Hereditary pancreatitis: new insights, new directions. <span><span class="ref-journal">Baillieres Best Pract Res Clin Gastroenterol. </span>1999;<span class="ref-vol">13</span>:253–63.</span> [<a href="/pubmed/11030605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11030605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.witt.2013.1216">Witt H, Beer S, Rosendahl J, Chen JM, Chandak GR, Masamune A, Bence M, Szmola R, Oracz G, Macek M Jr, Bhatia E, Steigenberger S, Lasher D, B&#x000fc;hler F, Delaporte C, Tebbing J, Ludwig M, Pilsak C, Saum K, Bugert P, Masson E, Paliwal S, Bhaskar S, Sobczynska-Tomaszewska A, Bak D, Balascak I, Choudhuri G, Nageshwar Reddy D, Rao GV, Thomas V, Kume K, Nakano E, Kakuta Y, Shimosegawa T, Durko L, Szab&#x000f3; A, Schn&#x000fa;r A, Hegyi P, Rakonczay Z Jr, Pf&#x000fc;tzer R, Schneider A, Groneberg DA, Braun M, Schmidt H, Witt U, Friess H, Alg&#x000fc;l H, Landt O, Schuelke M, Kr&#x000fc;ger R, Wiedenmann B, Schmidt F, Zimmer KP, Kovacs P, Stumvoll M, Bl&#x000fc;her M, M&#x000fc;ller T, Janecke A, Teich N, Gr&#x000fc;tzmann R, Schulz HU, M&#x000f6;ssner J, Keim V, L&#x000f6;hr M, F&#x000e9;rec C, Sahin-T&#x000f3;th M. Variants in CPA1 are strongly associated with early onset chronic pancreatitis. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:1216–20.</span> [<a href="/pmc/articles/PMC3909499/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3909499</span></a>] [<a href="/pubmed/23955596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23955596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.yadav.2009.1035">Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, Bishop MD, Baillie J, Sherman S, DiSario J, Burton FR, Gardner TB, Amann ST, Gelrud A, Lawrence C, Elinoff B, Greer JB, O&#x02019;Connell M, Barmada MM, Slivka A, Whitcomb DC, et al.  Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. <span><span class="ref-journal">Arch Intern Med. </span>2009;<span class="ref-vol">169</span>:1035–45.</span> [<a href="/pmc/articles/PMC6785300/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6785300</span></a>] [<a href="/pubmed/19506173" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19506173</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.yadav.2010.131">Yadav D, Whitcomb DC. The role of alcohol and smoking in pancreatitis. <span><span class="ref-journal">Nat Rev Gastroenterol Hepatol. </span>2010;<span class="ref-vol">7</span>:131–45.</span> [<a href="/pubmed/20125091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20125091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pancreatitis-ov.REF.zenker.2005.1345">Zenker M, Mayerle J, Lerch MM, Tagariello A, Zerres K, Durie PR, Beier M, H&#x000fc;lskamp G, Guzman C, Rehder H, Beemer FA, Hamel B, Vanlieferinghen P, Gershoni-Baruch R, Vieira MW, Dumic M, Auslender R, Gil-da-Silva-Lopes VL, Steinlicht S, Rauh M, Shalev SA, Thiel C, Ekici AB, Winterpacht A, Kwon YT, Varshavsky A, Reis A. Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:1345–50.</span> [<a href="/pubmed/16311597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16311597</span></a>]</div></li></ul></div></div><div id="pancreatitis-ov.Chapter_Notes"><h2 id="_pancreatitis-ov_Chapter_Notes_">Chapter Notes</h2><div id="pancreatitis-ov.Author_Notes"><h3>Author Notes</h3><p>Dr Whitcomb is a physician-scientist who has dedicated his career to understanding the complexity of pancreatic physiology, pathophysiology and pancreatic diseases in humans. He is the principal investigator of the Hereditary Pancreatitis Study, and the North American Pancreatitis Study II (NAPS2), which includes more than 25 major pancreas centers in the United States. He also serves as Chief, Division of Gastroenterology, Hepatology and Nutrition at the University of Pittsburgh and UPMC. He is also the editor and webmaster of pancreas.org, and co-editor of Pancreas Education and Research Letter (PEaRL), which is patient-directed update, with Sheila Solomon MS, CGC. (available through pancreas.org). Dr Whitcomb&#x02019;s work is focused on personalized medicine, with emphasis on early detection and prevention of a variety of pancreatic disorders using next generation DNA sequencing, biomarkers, and comparative effectiveness research.</p><p>A specialized Pancreas Center of Excellence incorporating genetic testing and counseling early in the evaluation of pancreatic disease has been established [<a class="bk_pop" href="#pancreatitis-ov.REF.whitcomb.2012.418">Whitcomb 2012</a>].</p></div><div id="pancreatitis-ov.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 March 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>20 December 2010 (dcw) Original Submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK190101</span><span class="label">PMID: <a href="/pubmed/24624459" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24624459</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/phs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pkan/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK190101&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK190101/?report=reader">PubReader</a></li><li><a href="/books/NBK190101/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK190101" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK190101" style="display:none" title="Cite this Page"><div class="bk_tt">LaRusch J, Solomon S, Whitcomb DC. Pancreatitis Overview. 2014 Mar 13. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK190101/pdf/Bookshelf_NBK190101.pdf">PDF version of this page</a> (488K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#pancreatitis-ov.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#pancreatitis-ov.Definitions" ref="log$=inpage&amp;link_id=inpage">Definitions</a></li><li><a href="#pancreatitis-ov.Causes_of_Hereditary_Pan" ref="log$=inpage&amp;link_id=inpage">Causes of Hereditary Pancreatitis</a></li><li><a href="#pancreatitis-ov.Establishing_the_Diagnos" ref="log$=inpage&amp;link_id=inpage">Establishing the Diagnosis and Cause of Hereditary Pancreatitis in a Proband</a></li><li><a href="#pancreatitis-ov.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#pancreatitis-ov.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#pancreatitis-ov.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#pancreatitis-ov.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#pancreatitis-ov.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5644[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRSS1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=197131[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">UBR1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=134218[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DNAJC21</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1056[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CEL</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6729[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SRP54</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6690[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SPINK1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1080[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CFTR</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=11330[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CTRC</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5645[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRSS2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=51119[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SBDS</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3075968" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3075968" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22379635" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PRSS1</i>-Related Hereditary Pancreatitis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PRSS1</i>-Related Hereditary Pancreatitis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shelton C, Solomon S, LaRusch J, Whitcomb DC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27578509" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">PRSS1, SPINK1, CFTR, and CTRC Pathogenic Variants in Korean Patients With Idiopathic Pancreatitis.</a><span class="source">[Ann Lab Med. 2016]</span><div class="brieflinkpop offscreen_noflow">PRSS1, SPINK1, CFTR, and CTRC Pathogenic Variants in Korean Patients With Idiopathic Pancreatitis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cho SM, Shin S, Lee KA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Lab Med. 2016 Nov; 36(6):555-60. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29173301" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Targeted Gene Next-Generation Sequencing in Chinese Children with Chronic Pancreatitis and Acute Recurrent Pancreatitis.</a><span class="source">[J Pediatr. 2017]</span><div class="brieflinkpop offscreen_noflow">Targeted Gene Next-Generation Sequencing in Chinese Children with Chronic Pancreatitis and Acute Recurrent Pancreatitis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Xiao Y, Yuan W, Yu B, Guo Y, Xu X, Wang X, Yu Y, Yu Y, Gong B, Xu C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pediatr. 2017 Dec; 191:158-163.e3. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301428" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cystic Fibrosis and Congenital Absence of the Vas Deferens</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cystic Fibrosis and Congenital Absence of the Vas Deferens<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ong T, Marshall SG, Karczeski BA, Sternen DL, Cheng E, Cutting GR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25003218" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.</a><span class="source">[Pancreas. 2014]</span><div class="brieflinkpop offscreen_noflow">CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schubert S, Traub F, Brakensiek K, von Kopylow K, Marohn B, Maelzer M, Gaedcke J, Kreipe H, Stuhrmann M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pancreas. 2014 Oct; 43(7):1078-82. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24624459" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24624459" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042ad875f66d18aa0bbd31">Pancreatitis Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Pancreatitis Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:36:56-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D8D65E04180B100000000089F0335&amp;ncbi_session=CE8D8D65E042AD81_2207SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK190101%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK190101&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK190101/&amp;ncbi_pagename=Pancreatitis Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D8D65E042AD81_2207SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>